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ABSTRACT
McEwen, Timothy Ryan, Ph.D., Human Factors and Industrial/Organizational Psychology Ph.D.
program, Wright State University, 2012. Development and Evaluation of an Ecological Display
for the Detection, Evaluation, and Treatment of Cardiovascular Risk.

Ecological interface design (EID; Vicente & Rasmussen, 1992) is a discipline
that emphasizes the necessity of understanding the laws and constraints of a
domain in order to make meaningful design decisions. We applied EID principles to
create an ecological interface aimed at helping physicians with the detection,
evaluation, and treatment of cardiovascular disease risk (specifically for
hypertension and hyperlipidemia) and then evaluated it in two exploratory studies.
In the first study, twenty-three internal medical residents participated viewed data
from twelve patients (in six blocks) in a repeated measures study that measured
which risk factors participant felt required follow-up and if their treatment
decisions agreed with medically established guidelines (e.g., ATP-III for
hyperlipidemia and JNC-7 for hypertension). The results indicate that residents
were significantly more likely to follow up on metabolic syndrome when using the
ecological display (p <. 0004) and that in 3 of the 6 trial blocks, they were more
likely to choose treatment decisions that agreed with medical guidelines when using
the ecological display for LDL cholesterol. Two faculty and two residents
participated in our follow-up study, which included a simplified version of the first
study but utilized an interactive version of the display and where performance and
v

interactions were recorded and analyzed. It also included interviews regarding
usability issues. The results demonstrated a preference for greater guideline
agreement when using the ecological display in only one block of trials, even though
almost all participants reported high levels of confidence that their decisions were
in agreement with medical guidelines. The usability interviews suggested many
ways in which the ecological display could be changed in future re-designs in order
to better serve various user groups and purposes. The many positive reactions from
our participants, in conjunction with our results, suggest that that further design
and evaluation of the ecological display would likely be beneficial in medical
decision-making.
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1. INTRODUCTION
1.1.

Medieval Medicine
From the vantage of over 600 years of history, it is easy to look back at the

medieval times with some degree of cynicism about medical beliefs and knowledge
of that time. Mortimer (2008) suggests that modern people would likely view
medieval English medicine as “a bizarre mixture of arcane ritual, cult religion,
domestic invention, and freakshow” (pp. 191).
Medieval physicians (university trained) and doctors (not university trained)
relied heavily on various books and manuals to aid the diagnosis and treatment
process, which process Mortimer describes in the following:
“[Their manuals] include details of planets’ movements and eclipses of the
sun and moon. They also include advice about phlebotomy (letting blood)
and all twenty-four varieties of urine, as well as numerological methods of
establishing whether you are likely to die or not. The physician will need to
know when your illness started, so he can establish where the sun and moon
were at the time, as well as the planet governing the health of the inflicted
organ. Using these details, he will prepare a series of concoctions for you.
First, there is the purgative, to rid it of corrupt matter, either through
vomiting, defecation, or urination. Then there is the remedy. Alternatively
the physician may open a vein and let your blood. From his diagrams he will
1

work out exactly which vein to cut in order to bleed you appropriately. This
has as much to do with the moon and stars as with your symptoms. When
the moon is in Leo, he should avoid incisions of the nerves and the back. […]
When it is in Scorpio, he should avoid slicing into your testicles, anus, and
bladder. […] After the ordeal is over, you should expect him to advise a final
restorative process […]“ (p. 211).
If your remedy process includes a concoction rather than bloodletting, your
options might include consuming such colorful and questionable (by today’s
standards) treatments such as seven fat bats heads for diseases of the spleen or
flayed cat cooked in hedgehog and bear fat for quinsy (Mortimer, 2008).
Again, while English medieval medicine seems backwards to the modern
reader, Mortimer makes it a point to note that,
“Medieval people are not ignorant, in the sense of having no knowledge. It is
simply that their knowledge is very different from our own. They probably
have as much medical “knowledge” as we do, only it is based on astrology,
herbology, religion, a little direct experience, philosophy, fundamental
misconceptions about how the body works, a lot of hearsay, and a large
measure of desperation. When you extend this form of understanding to the
physicians and surgeons, and combine it with the ability to charge fees, you
realize that medical practitioners have colossal amounts of information at
their disposal and a wealth of experience. Unfortunately, not much of it will
help you in your sickness, and some of it is seriously dangerous, if not lethal
(p. 193).”
2

Medieval English physicians required years of training and education to earn
a medical degree in a manner somewhat similar to the physicians of today.
However, as Mortimer puts it, the difference between them and our physicians of
today was not in the amount of knowledge per se. Medieval physicians and doctors
had to consider the relationships of many variables in order to arrive at the proper
diagnosis and treatment plan just as the physicians of today do. The difference lies
primarily in the quality of their “knowledge.”
Today’s physicians do not have to rely on astrology, philosophy, hearsay, and
desperation because they have benefited from advances in anatomy and physiology
that have been a result of advances in science. Improved scientific methods have
allowed for the accumulation of a great wealth of medical knowledge that is more
firmly grounded in ideas and scientific models (i.e., “the Truth”) that lead to more
successful outcomes for the patient. This scientific medical knowledge is the heart of
what is known as evidence-based medicine.

1.2.

Evidence-Based Medicine & Practice
Timmermans and Mauck (2005) remark that evidence-based medicine is

broadly applied to many aspects of medicine including “conducting a statistical
meta-analysis of accumulated research, promoting randomized clinical trials, to
supporting uniform reporting styles for research, to a personal orientation toward
critical self-evaluation” (p. 18). Sackett, Rosenberg, Muir Gray, Haynes, and
Richardson (1996) define it as “the conscientious, explicit, and judicious use of
current best evidence in making decisions about the care of individual patients” (p.
71). This definition focuses more on the provision of care rather than on the
3

discovery of knowledge, which provides it with a practical slant. This definition
provides a good definition of what could be called evidence-based practice.
One of the problems facing physicians wishing to engage in evidence-based practice
is simply keeping up with the evidence base. The homepage for PubMed, a database
for scientific literature focused on biomedicine, boasts that it is comprised of over
22 million citations and growing (United States Library of Medicine [NLM], n.d.).
Even if a physician spent all of their time reading published research, there is
obviously no possible way that they could read and absorb everything. Expert
panels and committees help reduce some of the burden by creating guidelines and
best practices based on the literature. However, there is still a tremendous load on
the modern medical practitioner to stay up to date.

1.3.

Information Technology
Modern information technological solutions, such as electronic medical

record (EMR) systems, have great potential to help with information management.
Health information technology (HIT) can be programmed to take the most recent
medical evidence into account and provide support to physicians who access these
systems. These electronic systems can increase efficiency and potentially reduce
physicians’ cognitive load by automatically integrating data in meaningful ways: for
example, automatically calculating values such as body mass index (BMI) and 10year risk of cardiovascular disease (CVD) for the physician or by alerting the
physician to indicate that certain values fall outside of pre-specified boundary
conditions.

4

Off-loading some of the overwhelming amount of medical knowledge
requirements to HIT is a way of taking knowledge that would normally be expected
to be “in the head” and transferring it to “the world” (Norman, 1988). Designing HIT
systems to collaborate with and support human expertise leads to the creation of a
socio-technical system known as a distributed cognitive system (Lintern, 2007;
Hutchins, 1995; Hollan, Hutchins, & Kirsch, 2000). A major benefit of a distributed
cognitive system is that it reduces the tremendous cognitive load expected of a
single agent (i.e., the physician) for proper system performance (i.e., providing care
based on scientific evidence).
Practicing evidence-based medicine requires that physicians have access to
(1) patient data, (2) scientific knowledge of how to interpret the patient data, and
(3) information about the possible treatment options. If any of these three
components is degraded, then there is a significant possibility that the patient’s care
will be less than satisfactory. While the information technologies supporting
evidence-based medicine promise improved access to patient data, there is concern
that insufficient attention is being paid to the other components. Thus, there is a
fear that physicians may be simply overwhelmed with data, with little improvement
in their capacity to make better treatment decisions. If medical data is not
interpreted properly, it does little to aid understanding and is therefore not
informative and fails to meet its ultimate objective. Although data from medical
tests undoubtedly helps providers and patients make informed decisions that help
improve diagnosis and treatment, there are some issues in the interpretation

5

process that can lead to data failing to become informative, resulting in potentially
negative outcomes in diagnosis and treatment.

1.4.

Representations of Patient Data and Error
In previous research, we observed one physician review the test results of

about 12 patients in less than 10 minutes. While not able to ascertain the accuracy
of that physician’s performance, the speed at which that task was performed might
explain why the physicians in that office occasionally signed abnormal test results
off as normal (McEwen, Elder, & Flach, 2011).
Currently, most laboratory results are reported using alphanumeric
characters in a tabular format (see Figure 1). Given the similarities in the
alphanumeric characters it is not surprising that data is occasionally misinterpreted
or missed, leading to errors in decision-making.
Reason (1990) distinguishes between two types of error: slips and mistakes.
Physicians, like all humans, are prone to these types of error. In the context of
interpreting test results, a slip can occur when the provider intends to read the
numerical value for a particular biochemical (e.g., total protein), but instead
accidentally reads the value from the line above or below the correct value (e.g.,
albumin). A mistake, on the other hand, is a well-executed erroneous plan. That
erroneous plan, in turn, may have been the result of the aforementioned slip
example or due to the fact that the amount of data that must be considered taxes the
human mental capacity.
Healthcare providers often deal with data that is ambiguous (e.g., does the
patient’s cough indicate a viral or bacterial infection?). In some cases, many pieces
6

of information across multiple channels (such as multiple medical tests and patient
vital statistics) must be integrated, or prior history must be considered before a
proper interpretation can be made. Given the ambiguity inherent in patient health
data and the difficulty integrating multiple independent sources of data, it is
possible for providers to draw the wrong conclusions and misdiagnose the patient’s
condition, potentially leading to a decline in the quality of care.

Figure 1 Example of Commonly Ordered Laboratory Test Results

1.5.

Graphics as an Alternative
The general hypothesis motivating this research is our belief that alternative

means of data presentation, such as graphics, can potentially aid physicians to gain a
deeper understanding of the relationships in the data (Tufte, 2001). Specifically, we
7

propose to more effectively integrate patient data with the scientific evidence-base
concerning judgments about health and choices of treatment options. Our general
goal is to explore ways to better support evidence based practice through integral
graphic displays. The same information technologies that facilitate storage and
access of patient data offer significant opportunities to improve how that data can
be represented.
Graphics can have a positive impact on improving the accuracy and decisionmaking of providers and patients. Although some recommendations for improving
graphical displays of patient information have been made (see Figure 2; Douglas &
Caldwell, 2009), there are very few examples that have been actually implemented.
These few graphical displays—which have been developed in both academia and
popular culture (Leckart, 2010; Goetz, 2011)—are likely to have some advantages
over the alphanumeric format, but they remain at their core, fairly simple number
lines, bar graphs, or line graphs. These formats can make the search for abnormal
values quicker and more accurate, but they do little to integrate the data to reflect
the scientific knowledge base related to diagnosis and treatment. Thus, while
improving access to data, they may fall far short of the full potential to improve the
effectiveness of evidence-based practice.

8

Figure 2 Individual Health Report Example (Douglas & Caldwell, 2009)

1.6.

Purpose and Design Limitations
Current graphical displays for medical information have generally employed

a single-sensor-single-indicator format that improves access to specific data, but
that provides little structure for integrating that data to reflect underlying relations
that may be critical to understanding more global properties, such as the overall
9

health of the patient or the relative merits of various treatment options. Ecological
or semantic display design (Bennett & Flach, 2011; Vicente & Rasmussen, 1992) is
an approach to interface development that emphasizes the integration of
information to support effective decision-making and problem solving. Thus, this
brings us to the purpose of this dissertation research—to discuss the development
process and evaluation of an ecological graphical display that can be used to detect,
evaluate, and treat issues related to cardiovascular disease in a way that supports
clinicians in evidence-based practice.
The success of the ecological approach depends on the value of the underlying
scientific evidence-base. For example, an ecological approach applied to medieval
medicine would still not have produced an as effective of a display as one based on
modern medical knowledge. The effectiveness of evidence-based practice will
always be bounded by the quality of the underlying scientific models of
cardiovascular disease and treatment.
The goal of this research is simply to ensure that clinical decisions about CVD are
informed by the existing evidence-base. It is important not to confuse this work
with another potential goal for electronic medical systems – that is, to improve the
evidence-base through improved representations/models for medical researchers
(e.g., epidemiologists). This alternative goal is typically referred to as ‘scientific
visualization.’ While ecological interface design seeks to configure graphical displays
to represent patterns that reflect current scientific knowledge (i.e., existing models
of health), the goal of scientific visualization is to help medical researchers to
discover previously undetected patterns in the data (i.e., new models of health). For

10

example, our display is not aimed at helping cardiologists discover new
cardiovascular risk variables in the data. Instead we are focused on creating
something that can help early and mid-career primary care practitioners see the
data in the light of the health models and guidelines for treatment so that they can
use this information as the starting point in the decision making process.

11

2. ECOLOGICAL INTERFACES AND SEMIOTICS
2.1.

Ecological Interfaces
What is an ecological interface? It is important, first, to understand what it is

not. Some erroneously believe that ease-of-use or simplicity define an ecological
display. This is not true. An ecological display may require significant training
before use because the system being represented may be extremely complicated
and complex. It would be ideal if an ecological display could be so intuitive that no
training would be required, but the designer must balance this with the need to
represent the intricacies of the domain in question. In other words, the law of
requisite variety must be respected (Ashby, 1958), or else the display runs the risk
of inadequately representing the work domain and runs the risk of being unhelpful
or irrelevant at times. Neither the display nor designer should trivialize the work
domain in order to develop an overly simple display at the expense of one that
accurately reflects the work and the domain.
Bennett & Flach (2011) have defined an ecological display as an interface
that “must provide global and local structure (or invariants) in the representation that
correspond to the inherent structure in the domain and that specify the potential in
the relation to goals and values” [p. 137; italics in original]. In other words, it is an
interface or display that attempts to connect the underlying ecology (the structure,
rules, laws, regulations, opinions, etc.) of the domain to the graphical elements.
12

2.2.

Semantic Mapping
The definition provided by Bennett and Flach (2011) may be understood

more readily by understanding the concept of semantic mapping, which is the
fundamental principle of ecological display design. McGregor and Slovic (1986)
demonstrated the role of semantic mapping with a series of studies that required
participants to estimate runners’ marathon times using multiple low-level cues
about each runner (i.e., age, fastest 10K race time in the past year, number of miles
run for training in the 2 months prior to the marathon, and motivation).
In their first study, participants evaluated several graphical display types
(e.g., a bar graph, polar coordinate, deviation display, and Chernoff face) to
investigate which provided superior support to the time estimation task. Each of
these display formats had the various marathon run time cues mapped to the
various graphical elements. For instance, the cues were represented as the height of
a bar in the bar graph or the curvature of the mouth (or other facial feature) in the
Chernoff face display. The results of the first study indicated that participants were
more accurate when the using the Chernoff face displays. These results might lead
one to believe that this represents the power of configural or “object” displays.
Although the Chernoff face display led to more accurate responses, there was
some uncertainty about the reason. Was it due to the fact that the Chernoff faces
allowed all cues to be represented simultaneously in an integrated framework that
allowed for parallel processing (i.e., because it was a perceptually integrated
“object”), or was it due to something else? McGregor and Slovic considered that
there might be another reason for the performance difference, namely that some

13

facial features in the Chernoff faces were more salient than others (e.g. the mouth
curvature versus the height of the nose), which might lead participants to give more
credence to the cues that were mapped onto the more salient features. If parallel
processing and an integrated framework for the cues were the reason for more
accurate estimates, then similar performance should be obtained for any feature-tocue mapping. After all, all cues would be presented as an “object” display and share
whatever benefits gained from that format.
To test the effect of facial feature-to-cue mapping, McGregor and Slovic
conducted a second study in which they represented information from the same
marathon runners, but had mapped the cues in one of two mapping schemes: a wellmapped face and a poorly-mapped face. The well-mapped face display was designed
so that the more indicative the cue was (as measured by the amount of variance that
could be explained), the more salient the facial cue (as derived from Brunswick’s
lens model) assigned to it was. The poorly-mapped display took the opposite
approach and mapped the more predictive cues to the least salient facial cues. These
reverse mappings led to cases where the same information could result in extremely
different faces (see Figure 3).
The results of the second study found that the well-mapped faces led to
better performance than the poorly-mapped displays. In fact, the poorly-mapped
facial display led to worse performance than some of the original formats presented
in their first experiment, such as the deviation and polar-coordinate display. These
findings suggest that the superiority of the Chernoff face display was not due to the
fact that all cues were placed together in a coherent framework that allowed for

14

parallel processing. If so, then both the poorly- and well-mapped faces should have
led to similar outcomes. The fact that the same information presented in the same
graphical format could lead to disparate results is evidence that the mapping
between cues from the domain (e.g., running marathons) and display elements is
meaningful. It is this relationship between the domain and graphical elements that
is known as semantic mapping or semantics.

2.3.

Semiotics
What do semantics have to do with graphical displays? To answer this

question, it is important to have an understanding of semiotics, or the study of signs
and signifying, because the creation of a graphic display is the creation of Signs
(Nadin, 1988).
2.3.1. Dyadic Systems
A dyadic semiotic system is comprised of a Sign and a Concept (see Figure 4).
The Sign is sometimes referred to as a medium, representation, or interface. The
Concept is a belief, mental model, or knowledge that an agent has. Knowing what a
literal sign (such as a stop sign) means is a question of semiotics as is arriving at a
medical diagnosis. In both cases, an agent or observer must make sense of the Sign.
In a dyadic semiotic system, a physician would examine a patient’s symptoms (the
Sign) and arrive at a diagnosis and treatment plan (the Concept). Under a strictly
dyadic semiotic model, any diagnosis would be valid as long as the
diagnosis/treatment matched the symptom, such as prescribing antibiotics for a
patient who has all of the symptoms of a cold. In other words, the dyadic model

15

would fail to differentiate between a modern physician and the medieval English
doctor.

Figure 3 Examples of Different Cue-Feature Mappings (from McGregor & Slovic, 1986)
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Representa on,
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Meaning &
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CONCEPT
(Diagnosis)
Belief,
Mental Model,
Knowledge

Saussure’s Dyadic Model
Figure 4 Model of a Dyadic Semiotic System

However, most healthcare providers would probably believe that prescribing
antibiotics to treat the patient’s symptoms would be ludicrous without further
investigation because there would be no guarantee that the symptoms would be tied
the patient’s health and disease pathogenesis. The symptoms do not specify whether
they are the result of a bacterial, viral, or allergic origin. Instead, the semiotic model
must be expanded to include the health of the patient and the pathogenesis of the
disease in order to provide the appropriate care to the patient. By broadening the
semiotic system to include the health and pathogenesis, the dyadic model becomes a
triadic model (Pierce, 1931-1935; see Figure 5) by adding another circle to the
semiotic model. This third circle, representing the Ecology (e.g., the health and
pathogenesis of the patient), now allows the diagnosis to be mapped to something
deeper than the manifest symptoms.
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(Pa ent Health)
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Representa on,
Interface

CONCEPT
(Diagnosis)
Belief,
Mental Model,
Knowledge

Saussure’s Dyadic Model

Pierce’s Triadic Model
Figure 5 Model of a Triadic Semiotic System

In the first study by McGregor and Slovic, they hypothesized that the
marathon time estimate (i.e., Concept) should be more accurate with some graphical
display formats (i.e., Signs) than with others. The supposed reason for any
differences in display performance would be that there was something inherently
superior about the Sign that allowed the viewer to form a better Concept, such as
providing an integrated framework allowing for parallel processing. This reasoning
is dyadic.
However, the second study illustrated that even the same graphical format
can lead to different time estimates. That different times could result from the same
format is strong evidence that the time estimate must be based on something else in
addition to the display. It is difficult to describe what this other “thing” might be
within a dyadic framework because the dyadic ontology is limited to only the Sign
and Concept. A triadic framework can account for these findings by considering the
mapping to the Ecology. In the McGregor and Slovic studies, the Ecology is the
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domain of marathon running and the cues that predict run times. The second study
demonstrates that the relationship between the Ecology and the Sign (i.e., the
variance accounted for in the cues and the salience of the facial features in the
display) was meaningful for participants. This meaningful relationship does not
exist in a dyadic semiotic system because it does not exist within the ontology.
2.3.2. Triadic Systems
In a triadic system, the relationship between Ecology and Sign is known as
Meaning, while the relationship between Sign and Concept is the Interpretation
(Bennett & Flach, 2011). In a dyadic system, Meaning and Interpretation are
equivalent terms because the dyadic ontology does not contain more than one
relationship.
The traditional approach to display design has primarily been a dyadic
systems approach. In a dyadic framework of display design, the semiotic problem is
how to create a Sign that is related to the Concept (i.e. the focus is on the
Interpretation). This relationship usually takes form in the preoccupation of
ensuring that graphs and displays are utilizing the optimum colors, proper sizes,
proper positioning, type of graph (e.g., bar versus line graphs), proper typefaces,
etc., so that the observer can understand the display. However, just as a diagnosis
would be shortsighted if only the Interpretation relationship was considered, a
graphical display format would also be equally shortsighted if this were the case.
All graphical displays have a mapping between the Concept, Sign, and
Ecology, but if no effort is taken to ensure a quality mapping between the Sign and
the Ecology, then the mapping is arbitrary. This was the case in the first study in
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McGregor and Slovic (1986); their initial results that led to the superiority of the
Chernoff face format was the result of the accidental initial arbitrary mapping of
facial features to risk factors. If another mapping had been used for the facial
displays instead, the second study may very well have been a follow-up on one of
the other graphical formats.
Effective display design requires a conscious effort to map the display
features to the factors that are relevant to the domain “behind” the display (i.e.,
semantic map). Semantic mapping is the alignment of Interpretation and Meaning. It
changes the focus from getting an observer to understand the display to that of
understanding the domain, via the display. In some respects, this relationship can be
understood by the transitive property: if a = b and b = c, then a = c. In other words, if
the Ecology is accurately represented in the Sign (i.e., the display), the observer’s
Concept should be reflective of the Ecology. Thus, an ecological display is one that
has a strong semantic mapping.

2.4.

Understanding the Domain

If the fundamental principle of ecological interface design is semantic mapping,
then researching the domain is requisite in order for a designer to create an
ecological interface that will have a strong semantic mapping. The display must be
representative of the complexities within the domain to avoid trivializing the
domain ecology. The next chapter will describe the laws and constraints of the
detection, evaluation, and treatment (DET) of cardiovascular disease (CVD) in order
to describe the ecology.
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3. THE ECOLOGY OF CARDIOVASCULAR RISK
“Essentially, all models are wrong, but some are useful.”
--George Box (1987; p 424)

3.1.

Cardiovascular Disease
Cardiovascular disease (CVD) is an umbrella term for diseases related to the

heart and vasculature (Mendis, Puska, & Norrving, 2011). Some examples of
common cardiovascular diseases include coronary heart disease (CHD), myocardial
infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke,
transient ischemic attack, peripheral artery disease, intermittent claudication, heart
failure, ischemic heart disease, coronary artery disease, and cerebral vascular
disease (also abbreviated to CVD).
There are many factors that contribute to cardiovascular disease. These
include biochemical factors, sometimes referred to as clinical indicators (e.g., creactive protein, high density lipoproteins [HDL], low density lipoproteins [LDL]),
hemodynamics (e.g., systolic blood pressure), hereditary factors (e.g., family history
of CVD), and personal lifestyle factors (e.g., eating habits, alcohol/tobacco use, Body
Mass Index [BMI]).
The list of risk factors is much longer than what we have just identified here,
but when designing a visual display to aid medical decision-making, there is a
question of how many risk factors must be accounted for to make adequate
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decisions about diagnosis and treatment. Designers must make a decision about
how much data will be represented and how integrated that data will be. For
instance, if values for every single risk factor for cardiovascular risk were presented
in a display, it could easily overwhelm the user (and be prohibitively expensive to
obtain via laboratory tests). On the other hand, integrating all the data into a single
easy-to-read piece of information (e.g., healthy/unhealthy) could mean that domain
has been oversimplified to the point that the user will fail when dealing with
abnormal cases. Mathematical models are one way of accomplishing the reduction
in the system’s complexity by focusing on the risk factors that are the most
informative. Having a model to work from seemed like an excellent place to begin to
understand the domain and became our entry point into the creative process.

3.2.

Cardiovascular Disease Risk
3.2.1. Risk Types and Studies
There are two main classes of risk used in the medical literature, both of

which are products of their respective research methods and analysis techniques.
The first type is relative risk which is the probability of
contracting/developing/experiencing some health related event relative to
exposure. The outcome of a relative risk study is a ratio of the probability of the
event occurring in the exposed sample to that of a control sample. For example, a
relative risk study might produce a quantitative estimation of how much more likely
smokers are likely to develop CVD than non-smokers.
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The benefit of these types of studies is that they are, relatively speaking, easy
to conduct. However, the down side is that the risk factors identified from relative
risk studies do not lend themselves to integration with more sophisticated risk
models. Without these more sophisticated and comprehensive studies that can
simultaneously account for multiple factors and their interactions, it is difficult to
know how multiple factors might work in concert with each other to influence risk.
Fortunately, a number of these more sophisticated studies, large-scale
epidemiological studies with thousands of participants providing information on
many factors over the course of years and decades, have been conducted.
The second class of risk is absolute risk or the absolute percentage of risk for
experiencing an event given certain parameters. In the domain of CVD risk, one of
the most accepted and used definitions of general cardiovascular risk is the
probability of experiencing a cardiovascular event within the next 10-years
(D’Agostino, Vasan, Pencina, et al., 2008; Ridker, et al., 2007, 2008). The benefit of
using absolute risk is that the models used to derive risk from the various risk
factors can be used to reduce some of the system’s complexity and provide a
framework for understanding the domain.
Some of the epidemiological studies that have led to models of absolute risk
for CVD include the Prospective Cardiovascular Münster Heart Study with German
citizens (PROCAM; Assmann, Cullen, & Schulte, 2002), CUORE project with Italians
(Ferrario, Chiodini, Chambless, Cesana, Vanuzzo, Sega, et al., 2005), the Beijing
Cohort (Zhang, Attia, D’Este, Yu, & Wu, 2005), and the World Health Organization’s
MONICA project (multinational monitoring of trends and determinants in
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cardiovascular disease) which included 38 populations from 21 countries (Evans,
Tolonene, Hense, Ferrario, Sans & Kuulasmaa, 2001). Although each study differs
from the others (and therefore leading to different CVD risk models), many risk
factors are shared across models (see Table 1). As could be guessed, having multiple
models is an indication of disagreement of which model is more accurate, and by
extension, which risk factors to use.

Table 1 Top CVD Risk Factors as Identified in Six Epidemiological Studies
Research Study/Model
FHS

Reynolds

Beijing

MONICA

CUORE

PROCAM

Age
X
X
X
X
X
Total Cholesterol (TC)
X
X
X
X
X
Low-density lipoprotein (LDL)
X
High-density lipoprotein (HDL)
X
X
X
X
Triglycerides
X
Systolic Blood Pressure (SBP)
X
X
X
X
X
Diabetes Mellitus (DM)
X
X
X
Antihypertensive Medication Use
X
X
Smoker
X
X
X
X
X
X
Body Mass Index (BMI)
*
X
X
Hemoglobin A1c (HBA1c)
(If DM)†
Family CVD History (FHx)
X
X
X
High Sensitivity C-Reactive Protein (hsCRP)
X
Note. * BMI replaces the biochemistry levels in a simplified Framingham Risk Model
† The initial all-female cohort used HBA1c as a covariate, but the all-male cohort did not. HBA1c has been subsequently
removed from the risk calculation for both men and women.

3.2.2. Disease Risk Models
In the United States, there are two main competing risk models for CVD. The
first model, the Framingham risk model, is derived from the Framingham Heart
Study (D’Agostino, Ramachandran, Pencina, Wolf, Cobain, Massaro, et al., 2008),
which has led to more than 1200 research articles (Framingham Heart Study, 2011)
and is one of the most widely cited epidemiological studies. The Framingham risk
model is commonly used as a comparison for other epidemiological studies and risk
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models (Hense, Schulte, Lowel, et al., 2003; Brindle, Emberson, Lampe, et al., 2003;
Zhang, Attia, D’Este, Yu, & Wu, 2005).
However, the competing Reynolds risk model has demonstrated that it can more
accurately classify patients into respective risk categories (e.g., <10%, 10-20%,
>20% risk) than the Framingham model. The differences in reclassification are not
trivial or mildly incremental; some patients would be reclassified to highest risk in
the Reynolds risk model from lowest risk in the Framingham risk model and vice
versa. The reclassification would have a tremendous impact on treatment.
In spite of the apparent superiority of the Reynolds risk model over the
Framingham risk model, there are two factors against using it as a model for our
graphical display. First, the Framingham risk model only requires the information
obtained through the commonly ordered lipid panel test whereas the Reynolds risk
model requires the high sensitivity c-reactive protein (CRP) level in addition to the
lipid panel. The fact that a second test must be ordered in order to use this model
makes it more difficult and expensive to implement in a clinical setting. However,
the primary reason for not using the Reynolds risk model is that the Framingham
risk model has found greater acceptance among experts, including its adoption for
use in the Third Report of the Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults (Adult Treatment Panel-III or ATP-III; National
Heart, Lung, and Blood Institute, 2001).
The ATP-III report and guidelines have been based on a review of over 1100
scientific sources by leading experts in the field of cholesterol management/CVD
risk and is sponsored by the National Heart Lung and Blood Institute (NHLBI; part
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of the US Department of Health and Human Services [DHHS] and US National
Institute of Health[NIH]). This report has established a number of guidelines for the
treatment of hyperlipidemia. Given the preference by experts for the Framingham
risk model and due to its incorporation into the ATP-III, it would seem to be a better
source for understanding the domain until additional medical research can establish
a different model that is clearly superior and has broader consensus.

3.3.

Mapping the Ecology to the Display: Creating the Graphical
Display Elements
3.3.1. The Framingham Risk Model and its Representation
By adopting the Framingham risk model as the model for the basis for our

work, the factors that we must consider are patient sex, age, total cholesterol level,
high-density lipoprotein level, systolic blood pressure, whether the patient is taking
medication for controlling their blood pressure, smoking status, and whether the
patient has diabetes mellitus. However, simply knowing which factors are relevant
does not constitute a useful risk model.
What exactly is the Framingham risk model? The general cardiovascular risk
model, as calculated from the Framingham risk model, is a mathematical model that
is based on the Cox proportional hazards model (Cox, 1972), which is a multiple
regression technique. This model is typically used in the healthcare domain for
calculating expectancies of contracting, developing, or experiencing various
healthcare problems or mortality within a specified window of time (usually 10
years for CVD risk models). The Framingham risk model is noted as:
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Figure 6 The Cox Proportional Hazards Model

In Figure 6, the probability of experiencing a cardiovascular event within a
certain time frame (e.g., 10 years) is noted as ̂ . The baseline survival rate, or
percent of those who have not experienced a CVD event within 10 years, is denoted
as s0(10). The variable X represents the individual’s score on some risk factor I and
̅ is the population mean for risk factor i. The s are the regression coefficients
associated with each of the risk factors (see Table 2).
Table 2 Framingham Risk Model Correlation Coefficients, Baseline Survival Rates,
and Summed Means
β
Formula Component
Men
Women
Correlation
Natural Log of:
Coefficients
Age
3.061
2.329
Total
1.124
1.209
cholesterol
HDL
-0.933
-0.708
cholesterol
SBP (if not
1.933
2.761
treated)
SBP if treated
1.999
2.823
Smoking
0.655
0.529
Diabetes
0.574
0.692
Baseline Survival
S0(t)
0.88936
0.95012
Summed Means
23.9802
26.1931
∑β ̅

In that both the baseline survival rate and e are constants, the primary
drivers for the risk are expressions in the exponential function in Figure 7 or
difference score.
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∑

∑

̅

Figure 7 The Difference Score from the Cox Model

Risk is based on the difference between the sum of an individual’s scores (multiplied
by associated regression coefficients) and the sum of the mean scores (also
multiplied by the respective coefficients). If there is no difference between these
two summed products, then the sum of the product containing the observed values
is equal to the sum of the product containing the population means. In other words,
the difference score represents how different an individual is from the population
mean in terms of risk.
3.3.1.1.

A Note on Language.

The language of risk and risk factors can be hard to follow, so care must be
taken when reading and thinking about them. For instance, if a patient is unhealthy,
they will have a difference score that is positive. Usually, the word positive carries a
good connotation, but this is not the case. When a difference is positive, it is
negative, or detrimental, in the sense that it means that the patient has a higher than
average risk score. A negative difference is positive, or beneficial, in that it means
the patient has a good risk score.
Also relevant to this discussion on language is with the term risk factor.
Colloquially, risk factor carries a connotation of bad or something that increases
risk. However, a risk factor, as used in this document, refers to any factor that was
included in the ATP-III model, regardless of whether it has a negative or positive
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regression coefficient. Consider that HDL has a negative regression coefficient (see
Table 2), which one might expect to reduce risk. However, this is not always the
case. Sometimes the risk factors that one might consider to be detrimental or
beneficial have the opposite effect. The reason becomes more clear when Figure 7 is
rewritten as:
̅)

∑(

Figure 8 Rearranged Difference Score from the Cox Model

Although the sum of the differences of X and ̅ (multiplied by their respective
coefficients) is mathematically equivalent to the difference between the sum of all
Xs and sum of all ̅ s (also multiplied by their respective coefficients), Figure 8
allows one to calculate the unique contribution of each factor in the risk model. Due
to the fact that this expression is a comparison between an observed value from the
patient and the population mean, how much a risk factor influences risk is a function
of whether the observed value is greater than or less than its respective mean. With
this information, a contribution graph can be constructed to illustrate which factors
are the primary drivers of risk for a particular patient, which is the main purpose for
rewriting the Figure 7 expression in this manner. The benefit of determining the
unique contributions is that physicians can now be provided with a means of
quantitatively evaluating the severity of each risk factor in order to better support
treatment decisions.
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Table 3 Values for Labs and Vitals of a Hypothetical Patient
Risk Factor
Sex
Age
Total Cholesterol (TC)
HDL Cholesterol (HDL)
LDL Cholesterol (LDL)
Triglycerides
Takes BP Meds?
Systolic Blood Pressure
Diastolic Blood Pressure
(SBP)
Smoker
Diabetes Mellitus(DBP)
(DM)
CVD Risk

Value
Male
52
254
36
173
228
No
138
86
No
No
10%

Consider the patient in Table 3. The extent to which each factor influences
risk is not immediately clear. For example, which risk factor is the most important to
address first? Does that risk factor increase 10-year risk the most? Is it worse to
have total cholesterol at 254 mg/dL, an LDL cholesterol level of 173 mg/dL, or a
systolic blood pressure of 138? We believed that our graphical representation of the
Framingham risk model could help with this problem (see Figure 9).
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Figure 9 Graphical Representations of the Framingham Risk Model and Contribution Bar Chart

3.3.2. Graphical Representation of the Framingham Risk Model
The graphical representation for the Framingham risk model consists of two
major components (see Figure 9). The bottom half of Figure 9 is a contribution bar
graph based on the differences in observed scores from their respective means as
described earlier in Figure 8 (i.e., their unique contribution). The x-axis (ranging
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from -2.0 to 3.5 demarcated in increments of 0.5 units) is shared between the top
and bottom halves of this graph. This number line represents the range of possible
difference scores as calculated from the expression in Figure 8. There are two
contribution bars in the display. The bottom bar represents the (summed)
contribution of all risk factors that increase 10-year risk, while the top bar
represents the (summed) contribution of all risk factors that decrease 10-year risk
for the patient. Arrows serve to guide to the direction to which the bar is extending.
In Figure 9, age, total cholesterol, HDL, and systolic blood pressure increase risk
while smoking status decreases it.
Due to biological range restrictions (e.g., no person will have a blood
pressure of 500 mmHg or a total serum cholesterol level of 0) and to the fact that
continuous variables (i.e., everything but smoking status and whether the patient is
a diabetic) have been transformed using the natural log, the difference of the sum of
weighted patient scores and the sum of weighted population means will rarely be
more than 3.5 or less than -2. These values set the range of the graph’s horizontal
axes.
The top half of Figure 9 contains a graphical representation of the Cox
proportional hazard function that has been aligned to the Framingham model
parameters. The y-axis of the Cartesian plane is divided into three areas using three
colors. The coloring scheme follows the traditional convention of green, yellow, and
red to indicate good, warning, and bad, respectively. More specifically, these areas
and colors map onto a treatment options matrix (derived from the ATP-III
guidelines) that will be discussed shortly. For now, it should be sufficient to say that
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the risk levels used for the treatment option table are broken into three categories
of risk: less than 10% (green), 10-20% (yellow), and grater than 20% (red). The
patient’s 10-year risk value is plotted along the curve as a function of the difference
score mentioned earlier in Figure 8. We have drawn a line from the difference point,
to the curve, and to the patient’s risk score. We also project a horizontal line from
this point that reaches beyond this component to the treatment option matrix.
The purpose of an ecological or semantically mapped graph is to tie the
domain to the display, so that the domain is more transparent to the observer. This
graph has attempted to achieve this goal by showing how much each factor
contributes to the patient’s risk. Additionally, it demonstrates that risk is a
curvilinear function, which explains in part why sometimes risk factors with large
regression coefficients may only raise the patient’s risk a trivial amount. By now, it
is hoped that the concept of mapping graphical features to the domain should be
clear to the reader. Now that a model allowing for the calculation of risk based on a
number of risk factors has been represented graphically, the next step is to map
them to the diagnosis and treatment process. The next section will focus on this
mapping between the model and the treatment options for both cholesterol and
blood pressure.
3.3.3. Treatment Options and their Representations
3.3.3.1.

Treatment Options

This research is aimed at developing an aid for physicians and patients to
gain a better understanding of a patient’s CVD risk and allow them to make
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treatment decisions that use the guidelines as a basis. In treating a patient at risk for
CVD, each risk factor is important to address. We have chosen to address two of
these components in our display. The first is hyperlipidemia, or elevated lipid levels,
as a way of preventing atherosclerosis (a precondition of CVD). Hypertension is the
other component that we focused on, primarily due to its prevalence and convenient
access to relevant data. Obtaining a blood pressure from a patient is a standard part
of providing care, and given that it is a required part of the Framingham risk model,
there would always be blood pressure data available without the expense of
additional lab tests (as in the case of the c-reactive protein).
We have already briefly mentioned the ATP-III guidelines for treating
hyperlipidemia. Hypertension also has its own set of treatment guidelines as put
forth in the Seventh Report on the Joint National Committee on Prevention,
Detection, Evaluations, and Treatment of High Blood Pressure (JNC-7; Chobanion et
al., 2003). Both the ATP-III and JNC-7 guidelines from these reports create
constraints in the detection, evaluation, and treatment (DET) processes for
physicians. As constraints, these guidelines are important to incorporate into a
graphical display intended to aid providers in the DET process.
The ATP-III Treatment Options Matrix.

Although, the ATP-III explicitly states that it should not be considered a
standard of care (p I-2), it is likely the most comprehensive document on the topic
and is referenced frequently in the literature. As such, the ATP-III guidelines serve
as an excellent model for understanding the diagnosis and treatment process for
hyperlipidemia.
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The relationship between hyperlipidemia, atherosclerosis, and CVD stresses
the importance of the use of the lipid panel to screen for abnormal values in order to
treat dyslipidemia as the primary means of preventing CVD. Accordingly, the ATP-III
guidelines give LDL cholesterol the preeminent position in the treatment process,
where it is the primary target for reduction.
Curiously enough, it should be recalled that LDL is not included in the
Framingham risk model as a risk factor (although it is counted indirectly in obtained
“Total Cholesterol” value), in spite of its role in the treatment process. According to
the ATP-III guidelines, LDL is the primary target for cholesterol reduction for
treating hyperlipidemia. The second factor used to determine treatment for
hyperlipidemia is the 10-year risk as calculated from the Framingham risk model.
The ATP-III guidelines suggest treatments for the various combinations of LDL and
10-year Risk levels. The treatment options include Therapeutic Lifestyle Changes
(TLC; such as avoiding certain foods and increasing physical activity), as well as the
Drug Therapy (DT) treatment option. No Treatment (NT) is a third option if the
patient is healthy enough. These guidelines can be seen in Table 4. We have taken
these guidelines and created a graphical interpretation, which we call the treatment
option matrix (TOM; see Figure 10).
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Table 4 ATP-III Treatment Guidelines
Risk Category
LDL Goal

LDL level to initiate
LDL level to initiate
Therapeutic Lifestyle Drug Therapy (DT)
Change (TLC)

CHD or CHD Risk
equivalent

<100 mg/dL

 100 mg/dL

 130 mg/dL

2+ Risk Factors

<130 mg/dL

 130 mg/dL

10-year risk 1020%:
 130 mg/dL
10-year risk <10%:
 160 mg/dL

0-1 Risk Factor

<160 mg/dL

 160 mg/dL

 190 mg/dL
(160-189 mg/dL:
LDL lowering drug
optional)

The purpose of the TOM is to help the viewer visualize the treatment option
space. The red area represents the space where DT is recommended by the ATP-III
guidelines, while the yellow area represent the TLC recommendation. The green
area represents the NT space. This display contains a very explicit mapping from the
guideline data to the treatment options. Finding the recommended treatment in the
TOM is a matter of plotting a point using a two-dimensional Cartesian coordinate
system, where LDL level and 10-year risk are the respective abscissa and ordinate.
When the TOM is integrated fully into the ecological display, we include visible lines
that project from the axes to meet at the specified coordinates.
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Figure 10 The Treatment Option Matrix

The JNC-7 Bar Graph.

The Seventh Report on the Joint National Committee on Prevention,
Detection, Evaluations, and Treatment of High Blood Pressure provides guidelines
for treating hypertension. However, these guidelines are much simpler than the
multidimensional guidelines used in the ATP-III for cholesterol. The JNC-7
guidelines consider hypertension a condition of either elevated systolic or diastolic
blood pressure (SBP and DBP respectively). The specific guidelines for classification
can be found in Table 5.
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Table 5 Blood Pressure Classifications and Recommended Treatments (JNC-7)
BP Classification
SBP (mmHg)
DBP (mmHg)
Treatment
Normal
<120
and <80
NT
Prehypertension
120-139
or 80-89
TLC
Stage 1 Hypertension 140-159
or 90-99
DT
Stage 2 Hypertension ≥ 160
or ≥ 100
DT
The information contained in Table 5 lends itself easily to the creation of two
number lines in an ecological display for systolic and diastolic blood pressure
respectively. A number-line/bar-graph hybrid (known simply as the JNC-7 bar
graph) was created for representing blood pressure and can be seen in Figure 11.
Treatment for elevated blood pressure is somewhat similar to that of
hyperlipidemia in that treatment options are comprised of NT, TLC, and DT. The
green area (labeled “good”) in Figure 11 has the recommendation of NT. The yellow
area (labeled “pre” for pre-hypertension) has the recommendation of TLC. The areas
labeled “Stage 1” and “Stage 2” (the orange and red areas respectively) refer to
degrees of hypertension and both have the recommendation of DT. It is
recommended that although both should be considered with DT, those in Stage 1
should begin their DT regimen with a single blood pressure reducing drug, while
those in Stage 2 should begin their initial regimen with two or more drugs.
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Figure 11 The JNC-7 Bar Graph.
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3.4.

Mapping the Ecology to the Display: Assembling the
Graphical Elements
We hired a software developer to help us create a prototype of the ecological

display. This prototype included the Framingham model and contribution bar chart,
the TOM, and the JNC-7 bar graph. We also added a number line display (see Figure
12) as a means to enter and change patient data in the system (we did not have a
real database of patient data to draw upon).
The number line format consisted of number line representations of some
continuous data (e.g., age, total cholesterol, etc.) as well as some dichotomous
variables such as whether the patient had an existing heart disease or equivalent
(ExstHD). Some variables are dichotomous by nature (e.g., Is there a family history
of CHD?; FamHx). Others were (or could have been) continuous variables that were
treated dichotomously by the model (e.g., was the waist circumference greater than
40 inches [>40in] or fasting blood glucose greater than 110mg/dL [>110mg]). These
dichotomous variables were created as sliding buttons, such that the white portion
of the button indicated the selection (e.g., a white box surrounding the “N” indicates
that the patient does not meet the criteria).
The color disruptions along each number line correspond to different
severity categorizations for each respective risk factor. The boundary for the factor
“Age” at 45 does not come from any published research, but is simply the point at
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which age begins to have a detrimental effect on 10-year risk according to the
Framingham risk model.
The blue-ish box in the top left corner of Figure 12 is a button intended to
switch between male and female models (M/F), but this functionality was not
complete at the time of the study and was therefore ignored. The implication for this
was that all of our stimuli were males.
The colored boxes and arrows for some of the risk factors correspond to the
colors used for risk factors elsewhere in the ecological display. The colors serve as a
sort of legend for distinguishing among the various risk factors. For instance, the
dark brown color of diabetes in the number line interface is the same as the color
used to denote the unique contribution of diabetes in the contribution bar chart.
When all of the graphical components come together, they form the entire
ecological display (see Figure 13). This display is what we evaluated in this
research.

3.5.

Summary
This chapter has laid the foundation for understanding the work Ecology of

detecting, evaluating, and treating cardiovascular risk and associated diseases. The
Framingham risk model provides a list of important risk factors necessary to
determine the 10-year risk of experiencing a cardiovascular event for a patient. This
model also allows the unique contribution of each risk factor to be calculated,
allowing for comparisons about their influence, which in turn, can guide treatment
decisions. The ATP-III treatment model allows 10-year risk to be combined with
LDL cholesterol level in order to arrive at the recommended treatment for
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hyperlipidemia. The JNC-7 treatment model accomplishes the same, but for
hypertension. We have attempted to illustrate Meaning by mapping the Ecology to a
graphical representation in order to aid physicians and patients to understand this
Ecology. The next chapter will discuss how the aims of this display will be evaluated.
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Figure 12 The Number Line Format
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Figure 13 The Ecological Display
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4. STATIC DISPLAY EVALUATION
“If we knew what we were doing it wouldn’t be [called] research.”
--Attributed to Albert Einstein

4.1.

Research Overview
4.1.1. Research Plan and Goals
In order to evaluate the ecological display, we decided that the basic research

method would entail having participants complete four tasks under what we call the
detection, evaluation, and treatment (DET) framework, which was modeled after the
implied workflow processes in the ATP-III and JNC-7 guidelines (NHLBI, 2001;
Chobanion, 2003). The tasks under the DET framework would require participants
to view the data from a number of patient cases in one of multiple display formats
and then make decisions and judgments regarding the presence, risk, and treatment
of hyperlipidemia and hypertension.
These four tasks were: (1) the concern task to measure participants’ concern
level for each patient case, (2) the follow-up task to identify differences in which
risk factors were perceived to require follow-up due to display format, (3) the
treatment decision task to examine whether the display format would lead
participants to select treatment options that were more likely to agree with ATP-III
and JNC-7 guidelines, and (4) the ranking task to determine if display types were to
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allow participants to more accurately identify the risk factors that increase 10-year
CVD risk the most.

4.2.

Method
After discussion with some medically trained advisors, we were informed

that these tasks would be too difficult for non-medically trained participants. They
also informed us that it would take about 6 minutes for participants to complete all
four tasks for each patient case and that we were likely to only get about an hour of
participation time from each participant. These constraints limited the number of
cases we could evaluate. However, some of these advisors were associated with an
internal medicine residency program at a local urban hospital and invited us to
conduct our research with their residents during one of their weekly training
seminars. This provided us the opportunity to collect data from more than 20
medically trained participants over the course of a few hours rather than a single
hour.
4.2.1. Participants
Twenty-three residents participated in the study. The mean age was 29.75
years (SD = 4.22 years, age range: 25 – 40 years). Twenty-one residents provided us
with information regarding their gender. Of those that responded, 57% (12)
indicated that they were female. Thirty-nine percent of participants self-identified
race as “White,” 13% as “African American,” 34% as “Asian,” 4% as “Other,” and
10% did not respond. None identified as Hispanic or Latino. The mean year in
residency was 2.19 years (SD = 0.8) of a 3-year program.
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Residents were verbally informed by the researchers, as well as their residency
program director, that they would not be required to participate in the study and
that their individual results would not be shared with hospital faculty. However, the
program director did encourage the residents to follow along as part of their
educational experience, even if they did not want to submit their responses for
research. All residents were provided with the opportunity to enter a drawing for an
iPad® as a matter of goodwill and as a way to encourage participation in the study
(although participation was not a condition of eligibility for the drawing). All
residents entered the drawing for the iPad and all consented to include their results
in our research study.
4.2.2. Materials
4.2.2.1.

Stimulus Packets

Upon entrance to the seminar room, participants were handed an informed
consent form and two packets of 8.5” × 11” inch white paper. The residents were
instructed to review and sign the consent form if they wished to participate in the
study and were further instructed not to look at either packet until given further
notice. The first packet contained the stimulus materials containing the patient
cases and the other packet contained the corresponding response forms.
Given our time constraint, we estimated that we would have time for twelve
male patient cases. One half of the cases had data presented in the number line
format while the other half contained data presented in the ecological display
(which also included the number line format). All stimuli packets contained the
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same 12 cases. The displays were all printed in color. All cases were male due to the
fact that the software used to generate the cases only worked for males at the time.
The stimulus presentation order had been randomized prior to administration in
order to reduce the probability of patient pairs (to be discussed shortly) appearing
sequentially. All packets presented cases in the same order.
Patient Pairs.

Given our intention to compare performance of different display types, and
given the relatively few cases and participants, we opted for a repeated measures
design. To reduce the potential of participants recognizing the case in the second
condition, we created the twelve cases so that each had another similar case in the
opposite condition. Each pair was matched in some respects but differed in others
(see Table 6). This meant that we altered many of the risk factors of one patient a
few points above or below its counterpart. Thus, no patient was exactly the same as
another, but was similar enough to one another to allow for some comparisons.
The primary factor to which we tried to match cases was the manner in which they
should be treated according to the medical guidelines. For example, Patients 1 and 2
were not exactly the same age nor did they have the same systolic blood pressure,
but both would likely require drug therapy according to the ATP-III guidelines for
treating hyperlipidemia. Pair 3 was the exception to this rule and had different
treatments for recommended treatment for systolic blood pressure.
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Table 6 Paired Stimulus Scenarios
Pair CVD
LDL
SBP
DBP
Context/Rationale
#
Risk
1
Med DT
DT
TLC Patient could quit smoking to drop to NT for
cholesterol
2

Low

NT

TLC

TLC Patient had enough risk factors to have
metabolic syndrome

3

Low

TLC NT/TLC TLC Although patient has low LDL cholesterol that
would not normally require treatment, their
diabetes places them into the high risk area
and requires TLC

4

Low

DT

DT

TLC Patient has many treatment modifying risk
factors that suggest TLC for cholesterol instead
of NT if fewer factors were present

5

Med

DT

DT

DT

6

High

TLC

TLC

TLC Patient whose risk is mostly determined by
age

Patient with relatively good cholesterol levels,
yet requires DT

Note. In Pair 3, the treatment for SBP in the ecological condition is NT and TLC in the number line
condition.

Response Forms.

The packet of response forms was 13 pages long—twelve pages for recording
responses for each case and one final page for collecting demographic data. An
additional space for notes was provided if3 residents felt that certain decisions
needed clarification or justification. A copy of this form may be found in Appendix A.
The next section will provide further details into these tasks and the measures used.
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4.2.2.2.

Performance Evaluation and Measures

Accuracy vs. Guideline Agreement.

Before we discuss the specific tasks from the response forms and
performance measurement, we need to make a distinction between accuracy and
guideline agreement. Accuracy is a loaded word—it carries a connotation of a
comparison between a response to some objective answer or standard. We did not
always have the benefit of a standard or guideline in this research. There were some
cases where even though there were standards, there was some flexibility in them.
For instance, one physician reported that they were completely confident in the
medical decision that they were making for the patient, yet were fairly certain that
their decision did not follow the ATP-III and JNC-7 guidelines and that the guideline
was wrong for that specific patient.
Although it might be tempting to say that this physician was wrong and that
the guidelines should be considered to be the objectively correct answer, it should
be noted that both the ATP-III and JNC-7 guidelines both defer to the physician’s
clinical judgment in all cases. Thus, instead of using the term accuracy to refer to the
extent to which a participant followed the guidelines and possibly give the false
impression that one graphical display allows one to make more “accurate” decisions,
we will use the term, guideline agreement, to indicate that one display might be able
to lead one to make decisions that are more likely to agree with the established
guidelines. The difference is subtle, yet extremely important.
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4.2.2.3.

The Tasks

Concern Task.

There are many CVD risk factors that can be combined to create high 10-year
risk, including cases where many factors appear to be relatively normal. This might
lead to a sense that the patient is healthier than they might otherwise be. We
wondered if the graphical presentation format of data might influence the
impression of a patient’s health and increase or decrease a physician’s sense of
concern for that patient.
The level of concern was recorded by having the participants indicate their
concern on a 4-point scale found at the top of the response form. The possible
answers were: (1) “Not concerned at all, seems to be in good health” (2) “A little
concerned, there is some risk present” (3) “Quite concerned, there are several
worrisome findings,” or (4) “Very concerned, there are significant worrisome
findings.”
We did not have any specific hypotheses to test, but given the various risk
levels and treatments that were recommended, we estimated that there would be
some ordering to the concern expressed (see Table 7).

Table 7 Expected Concern across Patient Pairs
Concern
Patient Pair
Greatest
1, 5
Middle
4, 6
Least
2, 3
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Follow-Up Task.

The follow-up task required the resident to review a list of risk factors and
indicate in a check box whether they felt that the particular risk factor should
require some follow-up. The follow-up response was strictly dichotomous—either
the factor was felt to require follow-up or not. Although there could have been many
degrees of concern for any of the risk factors, we wanted to use a dichotomy as a
means to find the “obvious” differences. This list of items to be considered included:
total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, systolic blood
pressure, diastolic blood pressure, diabetes, smoking, obesity, blood sugar, and
metabolic syndrome.
With this task, we evaluated the agreement within residents’ responses for
follow-up for each risk factor when using the two graphical displays. We compared
the responses for each participant and tallied the number of times that the
responses across both conditions differed using a sign test or binomial test
paradigm. For instance, if a participant chose to follow-up on a risk factor in one
graphical condition and not in the other, a tally mark would be made for the
corresponding graphical condition. If the responses were similar across both
conditions (either both indicated or not), no tally mark was made. The sum of tally
marks across all participants was an indication of the agreement between the
graphical conditions. A high tally is an indication of low agreement between the
graphical displays and suggests that one display format leads to differences in the
frequency at which participants endorse follow-up.
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With the exception of believing that there would be low agreement for
follow-up on metabolic syndrome in patient pair 3 (the only cases which met the
metabolic syndrome criteria) due to the pentagonal shape for metabolic syndrome
in the ecological display, we did not have a logical means for determining which
factors or graphical format would lead to any potential differences.
Treatment Decision Task.

We were interested in determining how residents would choose to treat the
various risk factors associated with blood pressure and cholesterol. For this task,
participants were given a matrix of risk factors and treatment decisions on the
response form and were asked to indicate how they would choose to treat each risk
factor by checking the corresponding box. The risk factors included: total
cholesterol, LDL, HDL, triglycerides, SBP, DBP, smoking, diabetes, obesity, and blood
sugar. The treatment options were: no treatment (NT), therapeutic lifestyle changes
(TLC), and drug therapy (DT).
Although we asked about treatment decisions for many risk factors, we only
focused on the treatment decisions for LDL cholesterol, SBP, and DBP because they
were the only factors for which we had specific treatment guidelines. As with the
follow-up task, we were measuring agreement. Guideline agreement was measured
similarly as before, but responses within each graphical condition were first
compared to the respective guidelines before being compared to the corresponding
graphical condition. For example, if a resident chose an answer that did not agree
with the guideline when using the number line but chose the answer that agreed
with the guideline when using the ecological display, a tally mark was awarded to
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the ecological display condition. Low agreement between the graphical conditions
indicates that residents chose a particular treatment more frequently in one
condition than the other and that the response was in agreement with the
corresponding guideline. In other words, one graphical condition had greater
guideline agreement.
Given the fact that we created the ecological display to help users to visually
make the connection between the data and the guidelines, we hypothesized that the
ecological display condition would lead to greater guideline agreement for LDL, SBP,
and SBP.
Ranking Task.

One difficulty of an alphanumeric table or number line is that it is difficult to
tell which risk factor has the greatest influence on a patient’s risk or, in other words,
which is the most important to treat. The six factors identified in the Framingham
model (i.e., total cholesterol, HDL, systolic blood pressure, age, and smoking status)
were presented for each patient on the response form. The residents were asked to
rank the risk factors for that specific patient case in terms of their severity as
specified by the product of the risk factor level and its regression coefficient from
the Framingham model.
Given the many risk factors that influence risk, we were interested in not
only whether residents were able to more accurately identify the top risk factor but
whether they could identify the top two and top three risk factors as well, regardless
of order. The rationale was that a physician might be able to identify the top risk
factors, but not necessarily in the precise order.
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The top two and top three risk factor components were scored such that the
precise order was irrelevant as long as the factors were included in the grouping.
For example, if the top three risk factors were HDL, LDL, and Age and a resident
ranked them as HDL, Age, and LDL, they would have correctly identified the top risk
factor, but not the top two risk factors. However, the resident would still have
correctly identified the top three risk factors. In theory, the task gets easier as more
factors are added because the list of factors grows and order becomes less
important.
We believed that because the ecological display provides the unique
contribution of each factor in the display (i.e., the contribution bar chart), we
hypothesized we would find that more residents would correctly identify the top
risk factors when using the ecological display. For this measure, we simply used the
count of participants who correctly identified the factors at each of the levels (i.e.,
the top, top two, and top three factors) rather than making agreement comparisons
as with the other tasks.
4.2.2.4.

Procedure

The study was conducted during the residents’ weekly seminar forum, which
took place in a small auditorium-style classroom (seating capacity approximately
40) of a local urban hospital. After having been introduced by the resident program
director, we used a PowerPoint presentation projected from an overhead projector
to introduce the EID display to the participants and explained the task instructions
by reading aloud from a script (see Appendix B). In the instructions, we asked the
residents to work as quickly and accurately as possible, but noted that accuracy was
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more important than finishing all cases. After the instructions, we allowed the
residents additional time to review and sign the informed consent. Residents were
also informed that they were free to leave at the conclusion of the study, but that we
would have a presentation about ecological displays and data visualization at the
conclusion of the study for those interested.
Once all residents had indicated that they were ready to begin, we instructed
them to turn over the stimuli and response packets and begin the study. The study
was self-paced, with an upper limit of three hours for completion. All residents
finished all cases within 1 hour and 45 minutes.

4.3.

Results
4.3.1. Concern
The distribution of concern levels for each case is located within the table

found in Error! Reference source not found.. The mode of all concern levels for all
cases was 2 (i.e., “A little concerned, there is some risk present”) with the exception
of pair 5 (cases 9 & 10) which had a mode of 3 (i.e., “Quite concerned, there are
several worrisome findings”). We believed that Pair 5 would be one of the Pairs with
the highest levels of concern. This was the case, but we were surprised that Pair 5
only had a mode of 3. In fact, all of the scores seemed to be lower than we thought,
particularly in light of the fact that nearly all cases were designed to require
treatment. It would appear that with the exception of pair 5 having a mode of 3,
there did not appear to be any meaningful differences in concern between display
types or between patient cases.
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Concern Across Patient Pairs
Cumulative Percentage of
Concern Responses
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0

0

1

0

0

0

0

0

1

0

1

0

Quite Concerned

7

7

1

5

1

4

5

4
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9
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14
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4
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Not Concerned

0

0

2

0

2

1

0

2

0

0

0

1

Display condition by Patient Pair

Figure 14 Expressed Concern Levels Across Patient Pairs

4.3.2. Follow-Up
Other than metabolic agreement for metabolic syndrome for pair 3, we did
not have any specific hypotheses to test with the follow-up task; we were simply
interested in determining whether participants responded differently between the
display types.
In the sign test paradigm, “successes” (x) are the number of times an event
occurs in one condition but not in the other. In our case, a “success” represented the
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event of a resident having chosen to follow-up using only the ecological display. The
number of trials (n) represents the number of events that resulted in a tie or where
a resident chose to follow-up (or not) in both conditions. As the number of ties
increase, the trial size shrinks for each comparison. If there are many “successes” or
“failures” (i.e., where follow-up was indicated only with the number line), then there
is little agreement between the two displays and one display is more likely to have
been used to indicate follow-up.
We used a two-tailed sign test (assuming a probability of 0.5) to
calculate the agreement between the two displays. The fraction-like numbers in
Table 8 represent this relationship with the number of follow-up indications with
only the ecological display (i.e., “successes”) on the left and number of trials the
right of the slash. The exact calculated probabilities are located beneath each
fraction.
Due to the many instances where n was low (e.g., less than 6) or where x was
approximately half of n (e.g., 4/8), we only performed seven binomial tests. Of the
seven tests, five proved to be significant. However, of the five significant differences,
two for Pair 3 should be discounted because they reflect differences in the TC and
Triglyceride levels between the associated cases (i.e., higher values in one format)
rather than differences due to graphical display.
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Table 8 Ecological Display Follow-up Differences by Patient Pair
Pair

TC
5/7
--

LDL
4/6
--

HDL
0/0
--

Trig
0/0
--

SBP
1/2
--

DBP
0/2
--

DM
0/0
--

Smk Obes
2/3 0/1
---

BS
1/1
--

MS
0/1
--

2

1/4
--

1/4
--

1/8
0.07

0/4
--

4/7
--

4/7
--

1/2
--

0/0
--

0/0
--

1/5
--

12/12
0.0004**

3

8/9
0.04*

1/1
--

0/1
--

9/10
.02*

0/2
--

0/2
--

0/2
--

1/2
--

1/2
--

0/0
--

1/4
--

4

2/2
--

0/1
--

3/4
--

0/0
--

6/6
.03*

7/9
.18

0/0
--

0/1
--

0/0
--

0/0
--

2/2
--

5

1/4
--

1/2
--

0/2
--

0/0
--

0/2
--

0/6
.03*

1/1
--

1/1
--

3/3
--

2/2
--

4/5
--

1

4/7
5/7 2/3 1/2 4/6 4/6 0/1 0/1 2/3 3/4
1/2
-----------Note: The top row of each Pair is a pair of numbers divided by a slash; the number to the left
is the number of “successes” (i.e., x) and the number to the right is the number of trials (i.e.,
n). The number on the bottom row for each pair is the probability of achieving x or more
successes out of n trials. The slightly greyed exact probabilities are the values that cannot be
explained by differences in the cases.
6

There was low agreement for Pair 2 on HDL, where more residents chose to
endorse follow-up while using the number line display, but this difference only
approached significance (p = .07, two-tailed). However the primary finding for Pair
2 is the low agreement for follow-up on metabolic syndrome, where residents were
significantly more likely to only follow-up when using the ecological format (p =
0.0004). This is not surprising given that the ecological display makes a point to
highlight this syndrome with red text and a pentagon shape while the number line
does not share such features.
More residents chose to follow-up only on SBP using the ecological display
for Pair 4 (p = .03), but we are unsure of the reason for this. More residents only
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chose to follow-up on DBP using the number line display for Pair 5 (p = .03), but we
are also unsure of the reason for this.
Over all, performance was rather similar for follow-up between the display
types. This similarity is reflected in low number of meaningful significant
differences and in the fact that of the 66 potential tests (6 cases × 11 risk factors),
there were only three instances where n was greater than 9. In other words, only
about 5% of the comparisons had 9 or more participants chose different answers
between graphical conditions.
4.3.3. Guideline Agreement
When reviewing the data, we noted that many participants chose to indicate
both TLC and DT for some patients. Given the fact that the medical guidelines always
recommend prescribing TLC along with DT, we coded these instances strictly as DT.
We hypothesized that the ecological display would lead to greater agreement with
the ATP-III and JNC-7 guidelines. We used a one-tailed binomial test (assuming a
probability of 0.5) to test the difference between the number of cases where
participants only chose to agree with the guidelines with the ecological display for
each patient pair. Table 9 contains the results for each test. There were only six
significant differences and all of them favored the ecological format. However, two
of the significant differences (SBP and DBP for Pair 3) were an artifact of the
different risk level values, rather than due to the display (i.e., the blood pressures
were borderline for one condition and not the other). Twenty-two percent of all
binomial tests resulted in support for our hypothesis that the ecological display
would lead to greater guideline agreement.
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Table 9 Guideline Agreement for the Ecological Display by
Patient Pair
LDL
k/n
p(X ≥ k)
10/12
0.02*
7/8
0.04*
4/7
0.5
7/7
0.007**
5/6
0.11
4/6
0.35

Pair
1
2
3
4
5
6

SBP
k/n
p(X ≥ k)
4/7
0.50
3/6
0.66
14/14
0.001**
3/5
0.5
0/1
1
6/6
0.02*

k/n
3/7
2/5
14/15
4/7
0/3
4/6

DBP
p(X ≥ k)
0.77
0.81
0.001**
0.5
0.125
0.34

4.3.4. Ranking
We created six graphs to examine any patterns that might have emerged in
the ranking responses (see Figure 15, Figure 16, Figure 17, Figure 18, Figure 19, &
Figure 20). These graphs plot the number of residents who correctly identify the
top one, top two, and top three risk factors that increase 10-year CVD risk for the
corresponding patient case in each Pair. For instance, in Figure 15, twenty-one
residents identified the top risk factor using the number line display and 18
identified the top factor when using the ecological display. Fourteen residents then
identified the top two risk factors (in any either order) and 15 identified the top
three risk factors (in any order) when using the number line format. The implication
of these results would suggest that the top risk factor was easy to identify using the
number line display but the second and third risk factors were more difficult to
identify.
On the other hand, when using the ecological display, most residents
identified the top risk factor (although fewer than when using the number line), but
confused the second most detrimental risk factor with the third most detrimental
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risk factor. This is likely because it is easier to identify the top risk factors in general
than it is to identify the specific order of those risk factors.
As a whole, these results provide insight into the difficulty of identifying the
top risk factors regardless of display type. Only in two Pairs (1 & 3) did more than
15 residents correctly identify the top risk factor. The other four Pairs tended to
have identification rates less than 60% for identifying the top risk factor.
Sometimes residents were able to identify the top (one-, two-, or three) risk
factors more easily when using the ecological display and sometimes it was more
difficult. We are not sure why these results are so conflicting, particularly in case of
the ecological display, which provides users with a graphical means to evaluate the
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Figure 15 Number of Correct Identifications by Number of Factors and Display Type for Patient Pair
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Figure 18 Number of Correct Identifications by Number of Factors and Display Type for Patient Pair
4

25

Pair 5

21
20
15

20

13

15
15

11

10

Eco
Num Line

5
0
1

2

3

Number of Top Factors (Cumulative)

Figure 19 Number of Correct Identifications by Number of Factors and Display Type for Patient Pair
5

64

# of Correct Identifications

25
20
15
10

Pair 6

20
18
10

Eco

10

Num Line

5

2

1

0
1

2

3

Number of Top Factors (Cumulative)
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4.4.

Discussion
With the exception of guideline agreement, our results were not what we had

expected. We imagined that there would be greater levels of concern expressed for
these patients than what was indicated, particularly in the cases of patients with 10year risk levels of 20% or more or those who should be on drug therapies for both
hypertension and hyperlipidemia. Perhaps we needed a scale with a greater range
to capture some of the nuances that we may not have been able to capture, such as
possible interactions of risk levels and treatment options.
In terms of follow-up, although we had no formal hypotheses, it was no
surprise to find that more residents endorsed follow-up on metabolic syndrome for
Pair 3, particularly for the fact that the ecological display practically spells out this
syndrome for the user and the number line does not. Given that Pair 3 was the only
Pair that had cases with metabolic syndrome, we would like to try and replicate this
finding in future research. This would particularly be important because these
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results might be spurious in the same way that we suspect that the other two
significant differences might be, given that we do not have a ready explanation for
them like we do for metabolic syndrome. Further research is certainly needed to
determine if these are real or spurious differences and why they occur or not.
We also found support for the ecological display as a means to increase
guideline agreement. Not every test proved to provide a significant difference
between the two formats, but every significant difference supported the ecological
display.
The ranking task results were also surprising in that so few residents could
correctly identify the top risk factors in any order. Even with the contribution bar
chart in the ecological display to provide the correct answers, many failed to identify
the correct factors. The pattern of correct identifications was not even consistent
among cases or Pairs. We are not sure what to make of these results and should be
the subject of future research.
We believe that there are at least three factors that influenced the results.
First, we believe that our participants may not have had enough training or
familiarity to take advantage of or trust the ecological display. Given the fact that
some answers are given to the user (e.g., metabolic syndrome, the unique
contribution of each risk factor), we are not sure why participants failed to utilize
these resources. Either way, we believe that more training and familiarity would go
a long way to improve performance when using the ecological display.
The second factor is that of the stimulus presentation method for the
ecological display. We believe that one of the compelling aspects of the ecological
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display is the ability to make changes in the display and see the dynamic changes
made in real time. We suspect that the static paper displays did not allow the
residents to benefit from these abilities.
The third factor to consider is whether we actually captured the essence of
the detection, evaluation, and treatment task for hypertension and hyperlipidemia.
Although our medically trained advisors reviewed our tasks, we still may not have
been asking the questions that are most meaningful or would allow the ecological
display to demonstrate its strengths.
We are aware of a number of limitations with our research and its design.
One question we cannot answer is whether either the number line or ecological
displays are better than the alphanumeric display. We did not incorporate the
alphanumeric display because we estimated that we would not be able to run
enough trials with participants to collect a meaningful sample size due to potential
time limits with physicians. We chose the number line for two reasons. First, many
of our medical advisors believed that anything would be better than the
alphanumeric format. Second, using the number line format against the ecological
display would allow us to compare a configural display (the ecological display) to a
separable display.
Second, all of our participants were evaluated simultaneously and had the
cases presented to them in the same order. We could not control for environmental
distractions or for any order effects. We initially planned to randomize the case
presentation order and meet with participants individually, but when the last
minute opportunity arose to conduct the research with 23 participants at one time,
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we made as many adjustments to the study as we could, but trade-offs had to be
made. In the end we could not control for order effects or environmental
distractions, but we benefited from having a larger sample size and more cases to
evaluate than we might otherwise would have.
Third, while we believe that insufficient training played a part in some of the
responses, there was another issue with the treatment responses. This was that we
were not able to differentiate between those who knew the guidelines and disagreed
with the treatment and those who did not agree with the guideline because they did
not know the guideline recommendation and chose differently.
Given the exploratory nature of this work, we tried to maximize the variation
in the cases we presented to our participants, while preserving some aspects, in
order to try to come to a sense of which questions might be important. To this end,
we created patient pairs. However, due to the number of risk factors and their
interactions, small differences (even just a few points) in the risk factors meant that
we could not compare cases to each other or control for the various risk factor
levels.
However, in spite of the weaknesses, we believe that this study has provided
a useful starting place for future research and has provided us with some more
refined research questions. As we mentioned, we were concerned about the inability
for participants to fully engage with the ecological display in this study, so we chose
to follow up with an additional study to compensate.
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5. DYNAMIC DISPLAY EVALUATION & USABILITY
INTERVIEWS
5.1.

Overview
The second part of this dissertation research consists of quantitative and

qualitative components. The quantitative component builds on the evaluation of the
ecological and number line displays during the previous study by having
participants use an interactive version of the ecological display in order to provide
users with a better sense of the domain dynamics. The qualitative component
included observations and interviews and focused exclusively on the ecological
display in order to provide us with a better understanding of potential usability and
usefulness issues.

5.2.

General Method
5.2.1. Participants
Five participants were involved in this study. Two were faculty physicians

with nearly 30 years of experience; one was associated with a department of family
medicine and the other was associated with a department of internal medicine. Two
participants were completing their residency in a family medicine/psychiatry
program; one was a first year resident, the other was a fourth year resident. The
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final participant was not a physician, but a registered nurse who had more than 20
years of patient education experience. Ages were not collected. Three participants
were female and two were male.
The nurse completed only one patient case during the quantitative
evaluation and therefore had her data excluded for that portion. However, she had
many valuable insights during the qualitative portion and her data was included
there.
Participants were personal contacts of the author or of the medically trained
advisors associated with this research and were associated with two Ohio medical
schools. Although sampling was primarily a matter of convenience, attempts were
made to obtain participants across a range of experience. Seven participants were
originally recruited, but two were not able to participate due to scheduling conflicts.
The study and interviews were conducted at each participant’s workplace
within a quiet office. Although the doors were closed, we could not eliminate all
distractions due to the nature of our participants’ work. We informed all
participants that they would have their name entered into a drawing for an iPad® in
exchange for their participation.
The Wright State University Institutional Review Board approved this
research.

5.3.

Part 1: Interactive Ecological Display Evaluation
There were two purposes of the quantitative evaluation. First, we believed

that a major benefit of the ecological display was that it would allow the physician to
engage in “what-if” experiments with patient data, allowing them to visualize how
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changes influenced the recommended treatment. We believed that this ability would
increase the frequency of making treatment decisions that agreed with the
respective guidelines when using the ecological display. To evaluate this hypothesis,
we had our participants complete a simplified version of the DET task used in the
previous study. In the simplified task, we also provided 12 trials (also from six
patient pairs) to the participants, but only asked participants to prescribe a
treatment instead of also deciding which factors to follow-up on or rank risk factor
severity.
Second, we believed that graphically representing the ATP-III and JNC-7
guidelines in the ecological display format would increase the physician’s
confidence in how well their prescribed treatment agreed with the respective
guidelines. This does not imply that the recommended guidelines are the correct
answers, but simply whether the participant felt that their decision matched that of
the respective guidelines.
5.3.1. Method
5.3.1.1.

Materials and Procedure

We used twelve electronic images to present the patient data in the present
evaluation. As with the previous study, patients were classified into six Patient Pairs,
with half of the trials being in the ecological condition and the other half in the
number line condition. Unfortunately, there was an error with the naming
convention used that led to the accidental use of dissimilar patients in one the pairs,
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so we had to discard the data from one pair and left us with five Pairs. These five
scenarios are outlined in Table 10.
We presented the stimuli to the participants with a laptop computer with a
16” monitor (with a screen resolution of 1600×900 pixels) that used the Windows 7
operating system. We used Techsmith’s Morae (version 3.2) to capture video of the
computer screen as the participant interacts with the displays. Morae also allowed
us to record both the participants’ faces and the audio dialog using the computer’s
integrated video camera and microphone. A portable computer mouse was also
provided for greater convenience.
The displays used in the number line cases measured 535×840 pixels and
were not interactive. They were presented to the physician using Windows Photo
Viewer®. For the ecological display condition, participants used the ecological
display software program that we developed. This software was simply an
interactive version of the ecological format used in the previous study that allowed
users to manipulated the various risk factor levels in order to effect change in the
display. The ecological displays measured 1420×840 pixels in dimension.
Stimulus presentation order was not randomized because we were worried that full
randomization may have left us without any completed pairs to use for comparison
because of the low number of participants and did not know how many trials each
participant could complete in their allotted time.
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Table 10 Paired Stimulus Scenarios for the Interactive Evaluation
Pair #
Cholesterol Tx
SBP Tx
Context/Rationale
Patients could quit smoking to
move from DT for cholesterol
1
DT
DT
to NT

2

3

NT

TLC

Patients had enough risk
factors to have metabolic
syndrome

TLC

Although patients have low
LDL cholesterol that would not
normally require treatment,
their diabetes places them into
the high risk area and requires
TLC

NT

4

TLC

NT

5

TLC

TLC

Patients have many treatment
modifying risk factors that
suggest TLC for cholesterol
instead of NT if fewer factors
were present
Patients with high 10-year risk
due primarily to age

In the task instructions, we asked participants to prescribe and verbalize
their treatment decision for both cholesterol and blood pressure for each trial. As
with the previous study, the treatment options were no treatment (NT), therapeutic
lifestyle changes (TLC), or drug therapy (DT). We avoided interrupting the
participants when possible; only interrupting for clarification.
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5.3.1.2.

Measures

Guideline Agreement.

We had two measures for guideline agreement, one for ATP-III and one for
JNC-7. Given the small sample size, we defined guideline agreement as the number
of participant responses that matched the guideline recommended treatments for
each condition (hypertension and hyperlipidemia) for each patient trial.
Guideline Confidence.

We measured guideline confidence for both ATP-III and JNC-7 guidelines. To
measure confidence, we asked participants to rate how confident they were that
their decision matched that of the respective guideline on a 7-point scale (1= Not at
all confident and 7 = Extremely confident). If a participant failed to mention the
rating before moving on to the next trial, we briefly interrupted the new trial and
reminded them to provide ratings for the previous trial.
5.3.1.3.

Procedure

Once we had made contact with our medically trained participants, we
arranged to meet with them in their respective offices. Upon arrival, we provided a
brief overview of the study and provided an informed consent form from which we
obtained their written consent. While participants reviewed and signed the consent
form, we set up the laptop computer on a desk in an area that the participant
designated.
After obtaining participants’ consent, we opened up a sample number line
trial for the participant to view while we read from a script detailing the task
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instructions (see Appendix C) and describing how to interact with Windows Photo
Viewer® to advance through the number line trials. We also informed participants
that they would be able to review their answers at the end of the block.
In that our appointments with the physicians were limited to 60 minutes, we
wanted to ensure that we had time to collect data from the DET task for both
graphical conditions as well as an interview. To ensure that there was time left for
the interview, we had to limit the time spent on the DET task. We limited the time
allotment for each graphical condition to about 10 minutes. With the addition of the
instructions, consent review, and set-up, the total duration of the DET task was
about 30 minutes. However, these times are approximate because the purpose of
the time limit was to allow us some time for the interview, not timing how long it
took to complete a trial. If a participant was in the middle of a trial after 10 minutes
had elapsed, they were allowed to finish the current trial before we moved on. This
process also meant that some participants did not finish every trial.
Once the participant had finished the last trial, we opened a sample
ecological display and read from a script that described the task instructions and
provided an introduction to the ecological display. As with the number line block,
we informed participants that they would be able to review their answers at the
conclusion of the block and that they would be able to interact with the display as
we read through the task instructions. We also instructed participants on how to
interact with the Windows 7 operating system to view and close each instance of the
ecological display program in order to navigate through the ecological block of
cases.
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5.3.2. Simplified DET Task Results
Given the few data points for the DET task, we have opted to provide the data
here in lieu of formal analyses (see Table 11).
For Patient Pair 1, all four participants made decisions in agreement with the
ATP-III guidelines and 3 of 4 participants agreed with the JNC-7 guidelines when
using the ecological display while not making any decisions in agreement with the
number line display. Display type seemed to have little effect for the other Patient
Pairs as demonstrated by the similarity in scores between the display types (e.g., 0
vs. 1 for ATP-III or 4 vs. 3 for JNC-7 in Patient Pair 2).
Guideline confidence was high across all Patient Pairs. Almost all participants
reported confidence scores of 6 or 7. Only participant S3 (30+ years of experience)
chose confidence scores other 6 or 7. In Table 11, we have highlighted participant all
of S3’s Confidence scores below 6 in gray. Note that with the exception of the
ecological display for Patient Pair 1, all responses less than 6 are for the number line
condition. We wonder if this participant was better “calibrated” than the others,
given that there seemed to be some measure of overconfidence for all participants
given the lower levels of guideline agreement.
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Table 11 Guideline Agreement and Confidence Tables
Pair
1

2

3

4

5

Guideline Confidence
ATP-III
JNC-7
NL
ECO NL ECO
7
7
7
7
6
7
7
7
5
7
7
5
6
6
6
6

Agreement

Guideline Agreement
ATP-III (3)
JNC-7 (3)
NL
ECO
NL ECO
2
3
2
3
2
3
2
3
1
3
1
2
2
3
1
3
0
4
0
3
JNC-7 (2)
NL ECO
2
2
2
1
2
2
2
2
4
3

ATP-III
NL
ECO
7
7
6
7
3
7
6
6

JNC-7
NL ECO
7
7
6
7
5
7
6
6

Agreement

ATP-III (1)
NL
ECO
2
2
2
1
3
2
2
2
0
1

JNC-7 (2)
NL ECO
2
2
3
2
2
2
--2
3

ATP-III
NL
ECO
7
7
6
6
4
6
---

JNC-7
NL ECO
7
7
7
7
7
7
---

Agreement

ATP-III (2)
NL
ECO
2
2
3
2
2
2
--2
3

JNC-7 (1)
NL ECO
3
2
3
3
2
2
--0
0

ATP-III
NL
ECO
7
7
6
6
2
6
---

JNC-7
NL ECO
7
7
7
7
7
7
---

Agreement

ATP-III (2)
NL
ECO
3
3
3
2
2
2
--1
2

JNC-7 (2)
NL ECO
3
3
3
3
----0
0

ATP-III
NL
ECO
7
7
6
6
-----

JNC-7
NL ECO
7
7
7
7
-----

Agreement

ATP-III (2)
NL
ECO
3
3
3
3
----0
0

Participant
S1
S2
S3
S4

S1
S2
S3
S4

S1
S2
S3
S4

S1
S2
S3
S4

S1
S2
S3
S4

Total Guideline
Agreement

3

9

6

9

Note. Guideline treatment recommendations are in parentheses in the LDL Tx and BP Tx column
headings; 1=No Treatment, 2=Therapeutic Lifestyle Change, 3=Drug Therapy.
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5.4.

Part 2: Ecological Display Usage
The second objective of this study was to investigate issues of use and

usability of the ecological display. To meet this objective, we observed participants’
usage and interactions with the ecological display as well as conducted semistructured interviews about their experiences with it.
5.4.1. Method
5.4.1.1.

Observations

During the quantitative portion of this study, we recorded participant
interactions with the screen capturing software. Two researchers reviewed the
resultant audio/video data and coded the participants’ usage behavior. Usage was
measured as the number of times that participants either referred to directly or
used the mouse to interact with the various graphical elements of the ecological
display (i.e., the number line, risk function curve, contribution bar chart, blood
pressure bar chart, treatment option matrix, and pentagons) while they completed
the DET task for each of the ecological display trials.
In that the number line element contained so many data elements and played
such a significant role in the DET process, we divided it into four smaller areas for
coding purposes. These areas were the top section (which includes the yes/no
switches for dichotomous variables along with the age number line), the cholesterol
area, the blood pressure area, and the risk value. Any time a participant navigated
(verbally or with the mouse) among these areas, we assigned a point to the number
line element tally. According to this coding scheme, participants used the number
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line at least three times every case (once for the dichotomous variables and age,
once for cholesterol, and once for blood pressure).
Discrepancies between the researchers were reviewed until consensus was
reached. However, there were a few cases in nearly every trial where coding was
impossible for verbal remarks. For instance, when addressing 10-year risk, many
participants made a comment along the lines of, “the patient’s risk is higher than I
would like” without verbally reporting or using the mouse to indicate which source
of data was used. Without accurate coding for these few cases, we are likely
underestimating actual usage.
5.4.1.2.

Interviews

Upon conclusion of the simplified DET task, we presented all five participants
with one final ecological display and began the short semi-structured interview. We
used three standard probes in these interviews to supplement and enhance our
understanding of usability issues related to the ecological display. These were: (1)
What do you think is confusing about the ecological display? Is it something that
training could resolve? (2) What features would you like to see implemented or
removed and why? and (3) Would you use the ecological display in your practice?
Why or why not?
All interviews lasted between 15 and 30 minutes. Once the interview section
had been concluded, we thanked the participants for their time and debriefed them
about the purpose of the study.
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5.4.2. Results
5.4.2.1.

Graphic Element Usage

Overall, the number line component had the most use (GM = 6.74, SD =3.44;
see Figure 21), followed by the treatment option matrix (GM = 1.53, SD = 1.64), JNC7 bar chart (GM = 1, SD = 1.28), function curve (GM = 0.79, SD = 0.97), pentagons
(GM = 0.42, SD = 0.94), and contribution graph (GM = 0.21, SD = 0.7). Taken
together, the number line component was used, on average, roughly 1.6 times more
often than everything else combined.
Although the number line component had the most usage, the JNC-7 bar
chart and ATP-III treatment option matrix were also used at least once on average
for each trial. The pentagons were little used, but the contribution graph was used
even less frequently. In some respects, this surprised us in that we believed that the
unique contribution of each factor would be important.
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Figure 21 Ecological Display Usage Statistics by Case and by Graphical Element

5.4.2.2.

Observations and Interview Responses

In response to the question about confusion with the ecological display, one
faculty physician stated that, “you need to be walked through [the ecological
display], but once you are walked through it, it’s pretty clear. […] Like anything else
computerized, you have to get used to looking at it. It’s really pretty clear.” All five
participants indicated that the ecological display was confusing at first glance but
that some instruction and experience with it made it simple to use.
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The sense of confusion from the ecological display came from a number of
sources. Perhaps unsurprisingly, all the graphical elements received a comment or
observation at some point. In that every element was implicated as a potential
source of confusion, we will present the results of the responses and observations
starting with the number line area, then the function curve, blood pressure bar
chart, treatment option matrix, and ending with the pentagons.
Number Line Area.

None of the participants mentioned the data-input number lines specifically
during the interview, but some did ask for clarification during the simplified DET
task. Two physicians asked once for clarification about how to read the graphical
switches for dichotomous variables (e.g., smoking) once; the nurse asked three
times.
There were some mixed responses to the coloration of the number line bars
and the colors used to indicate the risk factors themselves. Two physicians
mentioned that they felt the colors should be even brighter. Three physicians
mentioned that they liked the color schemes and felt that it helped distinguish the
risk factors from each other. However, the nurse kept referring to the colors as
“grey” and reported difficulty distinguishing between smoking, age, and diabetes
statuses.
Only one of the physicians mentioned the potential problem associated with
red-green color blindness. Two participants mentioned that they felt the red-yellowgreen coloration was helpful.
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There were complaints about the abbreviated labels such as “FamHx,”
“>110mg, and “>100mg.” The label for fasting blood glucose (i.e., >110mg) was
brought up by all participants at least once, either to verify what it was or if the
metric was supposed to be noted as “>110 mg/dL.”
Function Curve.

The function curve did not elicit any specific complaints, but there were two
comments about it being intimidating without training. There was a sense of
usefulness of this component, particularly when seeing the difference that toggling
smoking status has. One physician felt that the ability to see the change in risk that
smoking cessation could have was important for the patient to see. He stated, “[…] I
think the real beauty of something like this is that I’m cutting [the patient’s] risk
from 9.6 to 5. That’s hugely dramatic with just the click of a button. […] I think that
might convince a patient or two.”
Contribution Bar Graph.

One physician noted that it was difficult to notice or distinguish between risk
factors when the contribution of one risk factor is only a few pixels wide and is
placed next to another risk factor that shares a color or luminosity with the first. For
instance, a contribution of total cholesterol (dark blue) only 2 pixels might be lost if
placed next to contribution of systolic blood pressure (dark purple) that is 30 pixels
in width.
None of the participants had complaints about how the contribution bars
align with each other (i.e., the base of the top bar begins at the top of the bottom bar

83

instead of both originating in opposite directions from the y-axis), which is one issue
we expected to hear about. However, this may have been because we explained the
relationship in the instructions.
Blood Pressure Bar.

The nurse asked for clarification on the colors used in the bar. This makes
sense in that this bar uses not only the red-yellow-green color scheme to indicate
severity and treatment options, but it adds orange into the color scheme as well.
There are two DT options for blood pressure in the JNC-7 guidelines and we used
red for the most severe case and orange for the less severe case. Given that orange is
a mixture of both red and yellow; we can see how the color orange may send a
mixed message.
One of the residents did not immediately understand that the bars were
scaled according to the severity and treatment recommendation (e.g., the green
portion of graph field representing values for both SBP and DBP that were values
that did not require treatment) rather than being scaled numerically. When we
explained the logic to him, he indicated a preference for the severity/treatment
scaling over the strictly numeric scaling after all.
Treatment Option Matrix.

The only issue mentioned or observed with the TOM was when one physician
suggested that the colored regions have labels directly placed on them or to have a
descriptive label pop up on the mouse-over interaction.
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Pentagons.

One resident liked the pentagons, but reported that, “having the metabolic
syndrome and the risk factors [there] is kind of busy. Maybe you could click on [that
area] separately…click on it and have a box come up […] cuz it’s a little busy.” One
faculty physician stated that she “would remove the two pentagons because they
have not helped [her] at all.” There were no other quotations about the pentagons
directly, but we did observe one resident expressing surprise at noticing that one of
the trials met the criteria for metabolic syndrome and had not realized that fact
before he had looked at the pentagons.
Overall.

All participants indicated that they would like to use the display in their
practices, however, not all wanted the ecological display to be the format in which
test results were initially presented. Two of the physicians indicated that they
wanted the test results returned to them from the laboratory in ecological format
initially, one faculty physician wanted results presented in the traditional
alphanumeric format, and one resident wanted results presented in the number line
format. In spite of the mixed preferences, all participants felt that the ecological
display would be helpful to at least have easily accessible for “the complex patients.”
A few physicians mentioned that although they would like to use (or have available)
the ecological display, it would be necessary for the patients’ data to be
automatically populated (i.e., from an electronic medical record) into the display for
them to use it for decision-making purposes. Its use for decision-making was
contingent upon whether they had to enter the data manually or not.
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One commonly reported reason for using the ecological display was the
ability to see the Framingham model, ATP-III, and JNC-7 guidelines presented in a
visual format. Everyone made at least one positive comment on how the ecological
display reduced the need to “try and remember the guidelines.” As one resident
reported, the ecological display would “speed things up” for him because he would
not “have to think of the guidelines in his head.” Another resident agreed on this
point, and added that this format would “force people to use evidence-based
practice.”
All participants also mentioned that the ecological display would be a helpful
tool for patient education, particularly for the ability to make adjustments with the
data and see real-time changes. As one enthusiastic faculty physician put it,
“I like the ability to show the patient the impact of the changes that we’re
trying to make. Lovely for motivating patients. […] This is powerful for a
patient—they can actually see what they are doing. You’re giving the patient
something. […]This makes it easy and easy is really important. […] It’s nice to
have something simple and graphic in front of you to say [to the patient],
‘You’re doing the right thing,’ or ‘this is what we’re recommending’. Right
now EMRs are designed to deal with billing as opposed to helping us take
care of patients. This [the ecological display] helps you take care of patients.”
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5.5.

Discussion
5.5.1. DET Task
Taken as a whole, we believe the results from the quantitative portion hint at

a possible effect for the ecological display leading to greater agreement with the
published guidelines. The link between display and guideline confidence seems a
little weaker than that of agreement. Guideline confidence was particularly puzzling
between JNC-7 confidence and JNC-7 guideline agreement for Pairs 4 and 5 (both
display conditions) because in spite of the maximum confidence ratings, none of the
participants actually chose a treatment in agreement with the JNC-7 guidelines.
When using the ecological display, participants followed the ATP-III
guidelines in four of the five patient pairs. For the JNC-7 guidelines, participants
followed the guidelines with the ecological display in three of the five patient pairs.
Obviously the sample size limits the conclusions that we could draw from these
results, but the results at least offer a basis for warranting additional research. As a
pilot study, the ecological display seems promising.
We should also emphasize that even if additional future research were to
support greater guideline agreement, it would not necessarily indicate superiority
for the ecological display for the reason that some physicians felt that their
treatment was best for the patient regardless of what the guidelines suggested.
Following the guidelines does not necessarily equate to doing what is best for the
patient. Determining whether the ecological display influences physicians to follow
guidelines at the expense of what is best for the patient makes for an important
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future research topic, but is certainly outside of what we were able to accomplish at
this time.
In terms of guideline confidence, participants expressed greater confidence
that their treatment decisions matched the ATP-III guidelines in four of five patient
pairs, yet only once for the JNC-7 guidelines. However, it should be noted that for the
JNC-7 guidelines, participants’ responses for three of the five patient pairs were tied.
This is not so surprising given the degree of difference in steps required. The JNC-7
guidelines were much simpler in that they did not contain any information that was
not already contained in the threshold levels used to delineate the severity levels,
whereas the ATP-III guidelines required a 9-step process.
The same limitations apply to the results of the guideline confidence as for
the guideline agreement. Future research is certainly needed, but we are not sure
that asking about the confidence that their answer matches the guideline is the best
question after all. This again returns back to the issue of whether the guidelines are
the best thing for patients. A physician may feel very confident that their response
does not match that of the guideline but feel very confident that they are making the
best decision over all.
5.5.2. Interview and Observations
Aggregated together, all graphical display elements were used at some point.
We interpret this to mean that although there are some mixed feelings about some
of the graphical elements, each element could be a useful source of information for
users. However, it should be noted that these results do not necessarily negate the
less frequently used elements because we have reason to believe that they are a
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result of the task, not of their inherent usefulness. We had participants complete a
simplified DET task, which means that we asked participants to make a decision
about treatment, not to reason about their decisions. We assumed that the
reasoning process would have been inherent in the decision making process, but
this may not be the case. One medically trained advisor admitted that she thought
of the reasoning process as separate from the treatment decision-making process.
If this were true, then future research would likely find that the less frequently used
graphical elements (e.g., the function curve, contribution bar graph, and pentagons)
would become more frequently used. In terms of
5.5.3. Weaknesses
We recognize that we had to make some trade-offs that left us with some
drawbacks with this present study. First, our sample size was not large enough to
provide meaningful statistical information. Although we cannot make any
declarations of statistical significance, we believe that there is some evidence to
warrant further research. Second, in order to get participants to finish enough trials
(due to the time constraint) across both conditions, we had to standardize the
presentation order. This meant that we gave up the benefit of randomization, but on
the other hand, we were able to make comparisons within each Patient Pair.
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6. SUMMARY
6.1.

Study Overview
The purpose of this dissertation research was to evaluate the usefulness and

usability of an ecological display developed to aid providers in the detection,
evaluation, and treatment of cardiovascular disease. In order to accomplish this, we
used both quantitative and qualitative methods with physicians of varying degrees
of experience. Our primary purpose of carrying out this research was exploratory in
nature rather than designed to test any specific hypotheses. In this, we believe that
we have made some observations from the data that warrant further research.
First, when the cases in a Patient Pair met the criteria for metabolic
syndrome, participants were significantly more likely to only indicate the need for
follow-up when using the ecological display than the number line display. These
findings are not too surprising given the fact that the ecological display provides the
answer using the pentagon display along with some text.
Second, there was a trend for the ecological display to lead to greater
guideline agreement than with the number line display. However, this pattern was
only a trend, which was curious in light of the fact that the answer was figuratively
spelled out for the user. We suspect that a lack of familiarity and training partially
contributed to these findings, but we are unsure if certain risk factors or even a
general disagreement with the guidelines contributed as well. Perhaps combining
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multiple CVD risk models, such as the Framingham and Reynolds risk models along
with the ATP-III guidelines would lead to suggested treatments that physicians
would be more likely to agree with.
Third, we originally planned on comparing the number line format to the
ecological format because our initial inclination was that any display format would
have been better than the traditional alphanumeric format. We believe that it would
be worthwhile to go back and revisit our initial assumption, especially in the light of
having obtained fewer significant differences in every measure than we had
expected.
Fourth, the ranking results were mixed. We are not sure why this is the case
in spite of the fact that the answers were also figuratively spelled out for the
participants. There was a sense from our advisors and participants that
determining the most important risk factors for the patient was important, so we
would like to refine our method and try again. For instance, we think that creating
pairs that are matched according to the severity of risk factors instead of the
treatment option would be a good start.
Although we had some mixed results overall, we believe that we have made
an important first step in bringing forth an ecological display that physicians find
useful and usable. Although our display certainly requires further work before
“releasing it into the wild,” our partners and participants have received it with
enthusiasm and support, indicating to us that we are on the right track.
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6.2.

Ecological Interface Design
For us, the major lesson from McGregor & Slovic (1986) is that graphical

displays are only as good as the semantic mapping they have with their respective
ecologies. Not only must a user be able to make sense of the display, but the display
must also be a good representation of the domain in order to equate meaning with
interpretation. Representing the domain well requires a conscientious effort to
research the domain to discover the laws and constraints of the domain.
What we have tried to accomplish with our display is similar to that which
has been done in domains as varied as aviation (Amelink, Mulder, van Passen, &
Flach, 2005), power production (Schaefer, Little, Copper, & Easter, 1987; Woods,
Wise, & Hanes, 1981; Bennett, Payne, Calcaterra, & Nittoli, 2000), process control
(Bennett, Nagy, & Flach, 1997), military command & control (Bennett, Posey, &
Shattuck, 2008), and even fictional literature search (Petjersen, 1992). However,
one major difference between our work and that of the aforementioned work is that
we have chosen to use a correlational model as a functional constraint (i.e., the
Framingham risk model) rather than conceptual models (Pejtersen, 1992) or
physical systems described by (partial-) differential equations (Amelink, Mulder,
van Passen, & Flach, 2005, Bennett, Nagy, & Flach, 1997).
While there is nothing in the ecological interface design principles that
precludes the use of correlational models, we are unaware of their use in existing
work. We hope that our use of a correlational model will serve as an additional tool
in the ecological interface designer’s toolbox. Furthermore, we suspect the use of
correlational models may have pedagogical value because many in the human
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factors (and similar disciplines) are more familiar with correlational models than
they are of physical systems based on differential equations.
In our search for domain constraints, we had to rely upon the medical
science to tell us what was important. We assume that medical science has
improved since medieval times and that our current models of risk are far more
accurate and efficacious than what could be divined from astrology and planetary
motion, but validity of current medical models in the hands of those researchers.
Our job has not been to refine the medical science or create new models of risk, but
to use existing knowledge to develop a display capable of presenting the
complexities of the domain models to healthcare providers. We believe that the
positive response to our display from our participants indicates that we may be on
the right track, but we hope that we have not simply created a display that is
marginally better than the manuals used by medieval doctors. The success of any
ecological display used in healthcare will always depend on the quality of the
models it represents.

6.3.

Future Design
Although we believe that we are on the right track with our display, there are

still a number of design issues that we think should be addressed. The first, and
possibly the most obvious, is the need to address the issue of color in light of
potential problems for those with color blindness. We agree that our display should
be more usable to those who are color blind, particularly red-green blindness,
because those colors are prominently used throughout. However, we would hate to
lose the red-yellow-green/bad-warning-good cultural convention by eliminating
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them. However, we think that redundantly coding them with a texture or pattern
may be a potential solution.
Second, there were a number of complaints about the pentagons. At the same
time, a number of participants requested additional data, such as body mass index,
height, and weight. Given the suggestions and complains, we wonder if we would we
be better off removing the pentagon and replacing it with other data or another
graphical element. Regardless, additional research is needed in this area.
Third, we have two bars for systolic and diastolic blood pressure. There are
bars in the number line portion of the display as well as beneath the contribution
bar graph. From the systolic blood pressure contribution of the contribution bars
are a set of splayed lines that connect to the JNC-7 bars. On one hand, these lines
make an explicit connection between the risk model and the JNC-7 guidelines, but
we believe they do the job rather inelegantly. We wonder if the splayed lines are
necessary. Another aspect to consider is whether we need two sets of bars for blood
pressure. There is nothing contained in one set that is not in the other. The only
difference is that the bars in the JNC-7 area are scaled according to severity rather
than numerically. We could potentially eliminate one set of bars and keep them on
the same severity scale, which would free up some additional space for additional
information.
Fourth, there are also a number of factors that are dichotomously measured
in our display (e.g., waist circumference, fasting glucose, etc.) that our participants
have suggested to be displayed continuously on number lines. We agree that this
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would be a welcome addition to the display, even though the precise measurements
are not used in the Framingham risk model or criteria for metabolic syndrome.
Fifth, we have not addressed changes over time and historical data. While
this is a limitation of any number line or bar chart, not just our display, it still
remains an issue on how to (or if we should) represent multiple readings for the
various risk factors and outputs (e.g., 10-year risk levels and treatment options).
However, all of this raises the larger issue as to the scope of this display.
Although we agree with our participants and medical advisors about the
inclusion of additional data, we recognize the fact that we run the risk of trying to
display too much at once if we add any more to it. Data overload was one of the
problems we tried to address by creating this display in the first place. Creeping
featurism is a problem we want to avoid.
The future scope of this display will be determined by the development track it
lands in. On one hand, if this display were to be a stand-alone product (e.g., as an
iPad® app), then we would need to consider the inclusion of additional information
more closely because we do not want to leave our practitioners without the data
that they need. On the other hand, if this display were included in an EMR system
that was connected to a database of all patient data, then the need to include the
data in the display is less important because it would still be available in the system
for reference.
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6.4.

Concluding Remarks

As we mentioned earlier, we were not interested in creating a display from
which experts and specialists could extract new models of cardiovascular disease
and risk, but rather providing users with a quick entry into the decision making
process with the medical guidelines as the starting point rather than as the
endpoint.
We would also like to re-emphasize that while we attempted to make our display
easy to use, some of our participants struggled with it (although some may have just
disagreed with the guidelines). This should not be taken as evidence that our display
is “user-hostile,” but rather that we are asking medically trained physicians to
complete a difficult task in the face of ambiguity in that the “correct” treatment for
the patient does not necessarily have to correspond with the guidelines and some
participants wished for additional data. However, this goes back to one of the
misconceptions that people often have about ecological interface design. The point
is not to create a simple interface. The point is to provide an interface that allows
people to see, reason about, and interact with the ecology rather than the interface
per se. Complex domains require sophisticated displays in order to capture the
meaningful aspects of the domain. If a display is too simple, it runs the risk of
trivializing the domain and becomes useless (or harmful) when the display cannot
adequately represent the complexity of the domain. The law of requisite variety
(Ashby, 1958) must always be respected for a display to remain successful. This
may translate into the creation of a display that is sophisticated enough that may,
depending upon the complexity of the domain, require training.
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We hope that our display will have the opportunity to become refined after this
initial development process and become something that people will use, regardless
of a standalone product or as an integrated function of an EMR system. Whether or
not this display is implemented as a professional tool, we hope that it at least serves
as inspiration to designers to move beyond the dyadic world of colors, shading, and
font sizes and move into a triadic world of representing medical science and
guidelines.
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APPENDIX A
Data Collection Packet Sample
1.) How concerned are you about this patient’s health based on these results?
_______ Not concerned at all, seems to be in good health
_______ A little concerned, there is some risk present
_______ Quite concerned, there are several worrisome findings
_______ Very concerned, there are significant worrisome findings
2.) Place a check mark next to the cardiovascular risk factors that you would address with the patient:
Total Cholesterol

Smoking

LDL Cholesterol

Obesity

HDL Cholesterol

Blood Sugar

Triglycerides

Metabolic Syndrome

Systolic BP
Diastolic BP
Diabetes

3.) How would you treat the following risk factors in this patient? (Check corresponding box)
Treatment Option
Risk Factors

No Treatment

Lifestyle Change

Total Cholesterol
LDL
HDL
Triglycerides
Systolic BP
Diastolic BP
Smoking
Diabetes
Obesity
Blood Sugar
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Drug Therapy

4.) Rank the following CVD risk factors in order of severity for this patient by placing a number next to each risk
factor (1 = increases CVD risk the most to 6 = increases CVD risk the least; use each rank number only once):
Total Cholesterol

__________

HDL Cholesterol

__________

Systolic BP

__________

Diabetes

__________

Age

__________

Smoking Status

__________

Additional Notes:

Demographic Information
Gender:

___M

___F

Age:______________
Residency Specialization:_________________________________________
Year in Residency Training:____________________
What is your race?
___ White
___ African-American
___ American Indian or Alaska Native
___ Asian
___ Pacific Islander
____ Some other race or mixed (please specify):________________________________________
Ethnicity:
Are you Hispanic or Latino?

___Yes ___ No
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APPENDIX B
Script for Static Display Evaluation
Thank you for coming today. We appreciate Drs. [X] and [Y] for letting us come and
meet with you. The purpose of our visit is two fold; first, we want to share some of our work
with you in the field of graphical display design, particularly in ways of displaying patient
information. Secondly, we are here to solicit feedback from you in terms of our work and
how this display influences decision-making. To this end, we have provided you with a test
and ask for your participation in our research.
In front of you, you should find a packet of paper. The top is a letter of informed
consent for this research. As many of you may know, participation in any research is
voluntary. If you choose not to participate, you may find this to be an interesting exercise
anyway and we encourage you to follow along even if you decide not to return your
responses to us. We will not share your personal information or results with any faculty. If
you are interested, we will be happy to provide you with the group results when we finish
analyzing the data. Regardless of whether or not you choose to participate in the
experiment, the last page of the packet has a section where you can enter into a drawing for
an iPad. Please take a few moments to decide whether you want to participate and review
the informed consent document. Once we have your consent, we will proceed with the task
instructions.
You are to imagine that you have added a new male patient to your practice yesterday.
During your examination, you ordered a lipid panel for this patient. You were also able to
have some of the patient’s medical information transferred over from his previous
physician. Today, the results have returned from the lab and it is now time to review them
and make a decision about how to proceed.
We will provide you with this patient data in a moment once we have completed explaining
the task instructions. This patient information will be provided to you as a packet of papers.
Each page represents one patient. There are 12 pages representing 12 different male
patients. Your task will be to view this data and make decisions about treatment. Once you
have made a decision, please move on to the next patient and do not go back to review data
or change your answers from previous patients.
You will have access to the following medical data:




If he has existing heart disease (i.e., clinical CHD, symptomatic carotid artery
disease, PAD, abdominal aortic aneurysm)
If there is a family history of CHD (i.e., 1st degree relative with CHD; male <
55 or female < 65)
If the waist circumference is greater than 40 inches or 102 cm
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If fasting blood glucose is ≥ 110 mg/dL
If he was previously diagnosed with diabetes mellitus
If the patient smokes
Age
Cholesterol levels
 Total Cholesterol, HDL, LDL, and triglycerides
If he is currently on antihypertensive medication (Y/N)
Blood pressure
 Systolic and diastolic
10-year risk for cardiovascular disease (Framingham Model)

After reviewing this data, you will need to answer a number of questions found in the
packets that we have provided underneath the informed consent page. There is an answer
sheet for each patient. When you get to question 4, you are to rank order the severity of
each risk factor for this particular patient by assigning it a number from 1 to 6, where 1
means it increases that patients risk the most and 6 means it increases it the least. Use each
number only once. None of the risk factors should share a number. If you feel that you need
to explain any of your answers or believe that you would do something other than the
options we have provided, please feel free to use the additional notes section at the bottom
and feel free to write on the back of the page if need be. Please answer these questions to
the best of your ability.
You will be shown the patient data in two different graphical formats. We will now briefly
introduce these formats to you. As you can see, there are two numbers here. Number 1
represents the data as presented in a number line format. Some of the risk factors are
dichotomous. These are: existing heart disease, family history (fam Hx), waist
circumference above 40 inches, blood sugar above 110 mg/dL, diabetes, smoking, and
antihypertensive medication (noted as Tx). You will only see what is on the left-hand side.
Number 2 represents what is known as an ecological interface or display. It is made
up of section 1, or the number line format, as well as the three other sections. The first
represents the mathematical function used for calculating 10-year CVD risk according to the
Framingham model and a contribution bar chart graphic demonstrating the unique
contribution of each risk factor to 10-year risk. The bottom bar graph represents the risk
factors that increase risk for this patient while the top bar represents the factors that
decrease risk for this patient. The line projected off the top bar meets with the Framingham
function and indicates the 10-year risk. The lateral projection line takes us to the next area
of the display, or the area representing the ATP-III guidelines. The multicolored box
represents the decision rules advised by the ATP-III as a function of 10 year risk and LDL
cholesterol. Red represents the region associated with drug therapy, yellow with
therapeutic lifestyle changes, and green with no treatment. According to the ATP-3
guidelines, existing HD and diabetes will automatically place a patient in the high-risk
region, even though the calculated risk may be lower. This is represented by extending the
line up from LDL to place a point in the high risk region.
The pentagons underneath simply keep track of the number of treatment modifying
risk factors and the number of factors that contribute to metabolic syndrome. As these
conditions are met, these segments of each pentagon will fill up until they meet their
thresholds and will turn red to indicate that enough factors are present to modify goals and
treatment or that the patient may have metabolic syndrome.
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The last area in this display represents the jnc-7 guidelines. Green represents health,
yellow represents prehypertension, orange represents stage 1 hypertension, and red
represents stage 2 hypertension.
Again, there are 12 answer sheets that correspond to 12 different patients—hence
12 trials. The data from each patient trial will be in one of two graphical formats. Please
answer to the best of your abilities, make notes if you need to, and please do not go back to
review previous cases or change your answers. Are there any questions?
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APPENDIX C
CVD Risk Display Usability Protocol:
Dynamic Display Evaluation & Interview
1.
2.

3.

4.

Obtain consent to record video and audio
Read General Instructions
i. I will provide you with data from two sets of patients. Please evaluate the data
and make a decision regarding treatment for these patients’ cardiovascular
health. You will have 10 minutes to review each set of patients. At the end of
both sets, you will get a chance to go back and review any of the patients that
you have already examined and have a chance to change your answers.
ii. As you review the data from each patient, please speak your thoughts out loud
as if you were explaining your reasoning and decisions to a medical student or
resident. Additionally, we would like you to provide a ranking of how confident
you feel that your decision matches that of the JNC-7 and ATP-III guidelines.
This ranking is on a scale from 1 to 7, where 1 is “not at all confident” to 7
being “completely confident.”
Number line Format
a. Read instructions
i. You are to imagine that you have added six new male patients to your practice
yesterday. You ordered lipid panels for these patients as part of the
examinations. You were also able to have some of the patients’ medical
information transferred over from their previous physicians. Today, the
results have returned from the lab and it is now time to review them and make
decisions about how to proceed.
b. Give example number line format
i. This is patient data presented in a number line format. ExtHD means existing
heart disease, which in this case means clinical CHD, symptomatic carotid
artery disease, PAD, or abdominal aortic aneurysm. FamHx is family history of
coronary heart disease, specifically meaning a 1st degree relative with CHD;
male < 55 or female < 65. This is whether the waist circumference is greater
than 40 inches or 102 cm. This is the fasting blood glucose level and whether it
is greater than or equal to 110mg/dL. The reported blood pressure reflects the
average pressure over many past readings. **Explain the rest.**
c. You will have 10 minutes to review as many of these patients as possible. Please work as
quickly and as accurately as possible. Do you have any questions?
d. Allow 10 minutes for number line task completion
Ecological Display Format
a. Read instructions
i. This portion will proceed exactly as the previous portion, where you will
review the data from six different patients. Please continue to speak your
thoughts out loud and rank the confidence in your answers.
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b.

5.

6.

Give example of ecological format and demonstrate
i. This is patient data presented in what is known as an ecological display, which
means that attempts have been made to display the data within the context of
the scientific evidence and treatment guidelines. This is an interactive display,
so feel free to explore it by using the mouse as I explain the various
components. The left hand side is the number line format from the previous
task. You can click on the arrows and make adjustments to these values and
have their effects displayed elsewhere in the interface. This part is a graphical
representation of the Framingham model of cardiovascular risk. This is a
contribution graphic for the risk factors and their influence on risk. The
bottom bar is comprised of all of the risk factors that increase risk for this
patient and the top bar is comprised of the factors that reduce risk for this
patient. The colors in these bars correspond to the factors in the number line
portion of the display. Clicking on the I icon will allow you to see each of these
risk factors in terms of the most detrimental to the most beneficial for this
patient. Clicking it again will return it back the contribution bars. If you
project a line from the top bar up into the curve, you get the 10-year risk for
this patient. If you project a horizontal line from this point, you end up in the
ATP-III treatment options matrix. This matrix is a graphical representation of
the ATP-III guidelines for treating cholesterol. If you find the patient’s LDL
cholesterol level and draw a line up to intersect with the horizontal line from
the 10-year risk, you create a set of coordinates in this matrix. If this point is in
the red area, the ATP-III guidelines suggest drug therapy for treating
cholesterol. If it falls in the yellow area, it suggests therapeutic lifestyle
changes, and if it falls in the green, then no treatment for cholesterol is
suggested. In this ATP-III area, there are also two pentagons. The first is a
running total of factors that could constitute metabolic syndrome. The second
is comprised of the factors that would modify treatment goals. If this turns red,
then the treatment option matrix changes shape indicating the suggested
treatment changes. The final area represents the JNC-7 guidelines for treating
high blood pressure. This bar is scaled to the levels of severity. The green area
is the healthy range, the yellow indicates prehypertension, the orange
indicates Stage 1 hypertension, and the red represents Stage 2 hypertension.
c. You will have 10 minutes to review as many of these patients as possible. Again, please
work as quickly and as accurately as possible. Do you have any questions?
d. Allow 10 minutes for ECO task completion
Free response
a. Instructions
i. Now that you have completed both tasks, you may go back and review any of
the previous patients that you have reviewed.
ii. If the physician goes back to review previous cases, then ask:
1. What is it about this display that makes you want to revisit it?
2. Would you change your confidence rating? To what?
Interview physician
a. Would you use the ecological format in your practice?
b. What do you think is confusing about the ecological display?
i. Is it something that training could resolve?
c. What features or information would you like to see implemented or removed? Why?
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